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ABSTRACT 
 
Zoonotic transmission of Methicillin-resistant Staphylococcus aureus (MRSA): Prevention, 
Intervention and Policy Implications for the Equine Industry  
Ashley Erin Martin 
Raymond Lum, MPhil, MS 
Julian Mesina, DVM, Ph.D. 
 
Recognized as a hospital-acquired, community-associated, and zoonotic pathogen, methicillin-
resistant Staphylococcus aureus (MRSA) is a problematic disease-producing agent that concerns 
both humans and animals.  MRSA is a highly versatile organism with adaptable capabilities and 
horses, specifically, are particularly pre-disposed to MRSA colonization and infection.  
Colonized horses serve as MRSA reservoirs in the community and are capable of transmitting 
MRSA to humans.  Currently, infection control measures for veterinarians are outlined in the 
Compendium of Veterinary Standard Precautions for Zoonotic Disease Prevention in Veterinary 
Personnel (Compendium).  However, there is no known extensive document or protocol in place 
that offers preventative guidance for equine personnel outside of a clinic setting.  The purpose of 
this project was to examine existing information regarding equine MRSA transmission, as well 
as to thoroughly investigate the Compendium and assess the practicality of using it as a template 
for the equine industry.  Additional project aims included identifying the stakeholders and 
platform needed to begin the process of providing reasonable guidance for equine MRSA 
control.  This project consisted of literature reviews specific to equine MRSA transmission, 
assessments of barrier precautions and infection control measures, and interviews with experts 
on equine MRSA and Compendium co-authors.  Though not a perfect model, results indicate that 
the Compendium does have the capacity to be used as a template for the equine industry.  
Creation of infection control guidelines in the equine industry will be the result of a team effort 
by specialists, public health officials, and industry leaders actively working together.  Guidelines 
will gain strength, support and recognition in the horse world, if overarching regulatory agencies 
already firmly in place in the industry such as the United States Equestrian Federation (USEF) 
and the United States Hunter Jumper Association (USHJA) participate in guideline development 
and dissemination.  It is recommended that public health agencies approach the equine industry 
with a guidance perspective and partner with local horsemen and USEF/USHJA leaders in order 
to start the control process.  Future activities include linking public health agencies with the 
USEF/USHJA and developing a model infection control plan that is specific to personal horse 
farms and horse show grounds. 
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Introduction 
What is Methicillin-resistant Staphylococcus aureus (MRSA)? 
Methicillin-resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium that is 
commonly carried on the skin or in the nasal passages of approximately 25% to 40% of the 
healthy human population (CDC, 2009a; CDC, 2009b; CDC, 2009c; CDC, 2009d).  It is 
estimated that roughly 10% of all healthy and active horses also carry the pathogen in their nasal 
passages, intestinal tracts and on their skin (AVMA, 2009).  MRSA is a resourceful and 
adaptable pathogen that is capable of both aerobic and anaerobic respiration (Anderson, Lefebvre 
& Weese, 2008; Farr, 2004; Leonard & Markey, 2008).  It can produce biofilms, survive 
intracellularly, and cross species barriers (Anderson, Lefebvre & Weese, 2008; Farr, 2004; 
Leonard & Markey, 2008).  MRSA is able to cause a variety of conditions, ranging from mild 
skin infections to life-threatening sepsis in both humans and animals (Anderson, Lefebvre & 
Weese, 2008; Farr, 2004; Leonard & Markey, 2008).   
Most strains (more than 80%) of Staphylococcus aureus produce penicillinases and are 
resistant to several antimicrobial drugs (Anderson, Lefebvre & Weese, 2008; CDC, 2009a; Farr, 
2004; Leonard & Markey, 2008).   Thus, methicillin, a penicillinase-resistant drug, was 
developed and introduced in human medicine in the late 1950s to combat these particular strains 
of Staphylococcus aureus (Anderson, Lefebvre & Weese, 2008; CDC, 2009a; Farr, 2004; 
Leonard & Markey, 2008).  However, by as early as 1961, researchers noted that Staphylococcus 
aureus had developed mechanisms of conferring resistance to methicillin as well (Anderson, 
Lefebvre & Weese, 2008; CDC, 2009a; Farr, 2004; Leonard & Markey, 2008).  MRSA emerged 
in the United States during the 1970s and caused serious problems in many hospitals (CDC, 
2009a; CDC, 2009b; Leonard & Markey, 2008).  By the 1990s, severe nosocomial infections 
surfaced worldwide (CDC, 2009b; Leonard & Markey, 2008).  Currently, MRSA is becoming 
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increasingly resistant to aminoglycosides and fluoroquinolones, as well as other antimicrobial 
classes, making it a problematic pathogen of concern for human and animal species (Anderson, 
Lefebvre & Weese, 2008; AVMA, 2009; CDC, 2009d; Farr, 2004; Leonard & Markey, 2008).   
Persons and animals that are colonized with MRSA carry the bacteria on their bodies but do not 
exhibit signs of the disease (CDC, 2009c; AVMA, 2009).  Those who do develop signs of 
disease due to MRSA are considered to be infected (CDC, 2009c).  MRSA colonization may be 
short-term or long-term and illness due to infection can range from mild to severe (CDC, 2009c).  
A MRSA infection can result in death for both humans and horses (AVMA, 2009; CDC, 2009c).   
The increasing prevalence of MRSA in human and animal populations is of utmost 
importance and most definitely a worldwide public health problem (Anderson, Lefebvre & 
Weese, 2008; AVMA, 2009; CDC, 2009a; Farr, 2004; Leonard & Markey, 2008).  Moreover, 
infectious diseases and zoonotic pathogens like MRSA are continually emerging across the globe 
(Elchos et al., 2008).  Approximately 61% of known human pathogens are zoonotic, and roughly 
75% of all newly emerging infectious diseases affecting humans are zoonotic (Elchos et al., 
2008).  Thus, the potential for exposure to zoonotic pathogens like MRSA is great and travel, 
trade and global commerce continue to increase this potential exposure on a daily basis, making 
zoonotic disease transmission and infection a topic that is at the forefront of public health 
(Elchos et al., 2008).     
Severity of MRSA in Humans and Animals   
MRSA is the 10
th
 leading cause of death for Americans in the United States (CDC, 2009a; 
CDC, 2009d).  In hospitals and other healthcare facilities, it is the most frequently identified 
antimicrobial drug-resistant pathogen (CDC, 2009b; Maree et al., 2007).  A study released in 
2007 reported that MRSA caused more deaths in the United States than HIV/AIDS during the 
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2005 year (Klevens et al., 2007).  The prevalence of MRSA in humans is increasing and its rise 
can be attributed, in part, to community associated and zoonotic sources over the last 10 years 
(Baptiste et al., 2005; Khanna et al., 2007; Leonard & Markey, 2007; Maree et al., 2007; 
O’Mahony et al., 2005; Seguin et al., 1999; van Duijkeren et al., 2004; Voss et al., 2005; Weese 
et al., 2005a; Weese et al., 2005b; Witte et al., 2007).  While morbidity and mortality data in 
animals is scarce, researchers maintain that MRSA is an emerging pathogen of concern in animal 
species (Weese, 2005; Weese et al., 2005a, Weese & Rousseau, 2005, Weese et al., 2005b, 
Weese et al., 2008).   
Over the past decade, MRSA cases in companion and food animals have grown rapidly and 
researchers have seen a spike in MRSA infections among farmers, veterinary personnel, pet 
owners, and animal handlers (Baptiste et al., 2005; Khanna et al., 2007; Leonard & Markey, 
2007; O’Mahony et al., 2005; Seguin et al., 1999; van Duijkeren et al., 2004; Voss et al., 2005; 
Weese et al., 2005a; Weese et al., 2005b; Witte et al., 2007).  MRSA infections have been 
documented not only in horses (Anzai et al., 1997; Hartmann et al., 1997; Weese, 2005; Weese 
et al., 2005a; Weese et al., 2005b), cats (Bender et al., 2005), dogs (Pak et al., 1999; van 
Duijkeren et al., 2004), sheep (Goni et al., 2004), rabbits (O’Mahony et al., 2005), pigs (Voss et 
al., 2005), and chickens (Lee, 2003), but in several exotic animal species as well (Leonard & 
Markey, 2007; O’Mahony et al., 2005).  According to investigators, MRSA should be closely 
monitored because zoonotic transmission is a major threat for animals and their handlers 
(Baptiste et al., 2005; Weese et al., 2005a; Weese et al., 2005b). 
Public Health Significance of Equine MRSA       
Much research has been conducted on worldwide MRSA rates and outcomes in humans, but 
studies investigating the prevalence and persistence of colonization and infection in animals are 
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still lacking (Leonard & Markey, 2008).  Likewise, controlled studies examining the 
transmission between animals and humans and the efficacy of decolonization procedures are 
absent (Leonard & Markey, 2008).  Numerous studies, however, have shown high rates of 
MRSA colonization and infection among horse owners and horse veterinarians (Anderson et al., 
2008; Elchos et al., 2008; Hanselman et al., 2006; Seguin et al., 1999; Weese et al., 2005a; 
Weese et al., 2005b; Weese & Rousseau, 2005; Weese et al., 2008).  While these high rates of 
MRSA cases among horse handlers may be partly due to greater awareness and testing, experts 
in MRSA research confirm that MRSA infection is an important emerging disease in horses and 
it should not be taken lightly (Leonard & Markey, 2007; Weese et al., 2005a; Weese et al., 
2005b).   
Understanding that MRSA moves freely between horses and humans, the growing prevalence 
of MRSA in equines and their human associates is troubling (Leonard & Markey, 2007; Weese 
et al., 2005a; Weese et al., 2005b).  Since data does indicate that horse handlers who come in 
contact with a MRSA colonized or infected horse may also become colonized and/or infected 
and spread the disease further (Anderson et al., 2008; AVMA, 2009; Baptiste et al., 2005; 
Hanselman et al., 2006; Huijsdens et al., 2006; Lee,2003; Lloyd, D., 2006; Morris et al., 2006; 
Oehler et al., 2009; Tomlin et al., 1999; Vitale, Gross & Weese, 2006; Weese, 2005; Weese et 
al., 2005a; Weese et al., 2005b; Weese et al., 2008 Wulf et al., 2006; Yasuda et al., 2000), it 
follows that standard precautionary measures for MRSA prevention that are useful in reducing 
transmission in a variety of equine industry settings should be developed and implemented.  
Likewise, the formation of a MRSA infection control plan that is practical and effective in a 
variety of equine industry settings is needed to minimize the impact of colonization and 
infection, while further research investigates the practicality of routine screening for all animals. 
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Given that MRSA is a highly versatile organism with adaptable capabilities, researchers 
speculate that zoonotic transmission is a common occurrence and very much a public health 
concern (Walther et al., 2009).  If MRSA were to become endemic in the human or equine 
population, it would be nearly impossible to control (Walther et al., 2009).  Experts, however, 
are confident that precautionary measures and infection control plans can be successful at 
reducing transmission and minimizing risk, if accurately developed and understood before an 
outbreak occurs and aggressively applied when MRSA is first identified in an equine setting 
(Anderson et al., 2008; AVMA, 2009; Baptiste et al., 2005; Hanselman et al., 2006; Huijsdens et 
al., 2006; Lee,2003; Lloyd, D., 2006; Morris et al., 2006; Oehler et al., 2009; Tomlin et al., 1999; 
Vitale, Gross & Weese, 2006; Walther et al., 2009; Weese, 2005; Weese et al., 2005a; Weese et 
al., 2005b; Weese et al., 2008; Wulf et al., 2006; Yasuda et al., 2000).   
Public Health Justification for Equine MRSA Research 
MRSA is a growing concern for both human and horse health.  Colonized horses serve as 
MRSA reservoirs in the community and are capable of transmitting MRSA to humans (Weese, 
2007a; Weese, 2007b).  Research has documented that MRSA readily moves back and forth 
between horses and humans (Anderson et al., 2008; AVMA, 2009; Baptiste et al., 2005; 
Hanselman et al., 2006; Huijsdens et al., 2006; Lee,2003; Lloyd, D., 2006; Morris et al., 2006; 
Oehler et al., 2009; Tomlin et al., 1999; Vitale, Gross & Weese, 2006; Walther et al., 2009; 
Weese, 2005; Weese et al., 2005a; Weese et al., 2005b; Weese, 2007a; Weese et al., 2008 Wulf 
et al., 2006; Yasuda et al., 2000).  In particular, nasal and facial contact with MRSA colonized 
and/or infected horses and contact with contaminated fecal matter facilitate transmission (Weese, 
2007b).   
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The transmission of MRSA from colonized or infected horses to humans is a significant 
concern, especially given the frequent international movement of horses in the equine industry 
(Weese, 2007b).  MRSA has been identified in horses on several continents and both human-to-
horse and horse-to-human transmission has been documented by veterinary professionals and 
researchers in numerous locations (Weese et al., 2005a; Weese et al., 2005b).  Horses move 
extensively within the United States and between the United States and other nations for various 
reasons that include, but are not limited to, show jumping events, horse racing events, 
steeplechase events, polo matches, collegiate riding events, mounted patrol deployments and 
general private and public horse sales and auctions.   
The extensive national and international movement of horses, coupled with the emergence of 
MRSA as an equine pathogen, gives rise to a wider distribution of MRSA among human and 
equine populations making it a significant public health concern (Weese et al., 2005a; Weese, 
2007b).  Moreover, research suggests that MRSA may already be endemic in certain horse 
populations worldwide (Weese, 2007b).  Given that people who handle horses for occupational 
and recreational purposes come in very close contact with the animals on a routine basis, there is 
potential that MRSA is already much more widespread than recognized in horses and their 
handlers (Weese et al., 2005a; Weese, 2007b).  For these reasons, MRSA transmission and 
infection control as it pertains to human and horse health in an equine setting deserves further 
attention and research.                          
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Description of the Problem 
Recent research provides sufficient evidence that MRSA is transmittable between horses and 
humans in both directions, which results in colonization and infection in both species (Anderson 
et al., 2008; Hanselman et al., 2006; Leonard & Marley, 2008;  Oehler et al., 2009; Weese et al., 
2005a; Weese et al., 2005b;  Weese & Rousseau, 2005).  Thus, people who work with horses are 
at an increased risk of MRSA colonization and infection  (Anderson et al., 2008; Elchos et al., 
2008; Hanselman et al., 2006; Leonard & Marley, 2008;  Oehler et al., 2009; Weese et al., 
2005a; Weese et al., 2005b;  Weese & Rousseau, 2005).  Persons who work with horses in any 
capacity should be aware of the concerns regarding MRSA and should be equipped with the 
necessary tools needed to prevent transmission, control infection and reduce the burden of 
disease for themselves and their animals.   
Currently, standard precautionary measures for infectious disease control are outlined in the 
Compendium of Veterinary Standard Precautions for Zoonotic Disease Prevention in Veterinary 
Personnel (Compendium) (Elchos et al., 2008).  Developed by the National Association of State 
Public Health Veterinarians (NASPHV) Veterinary Infection Control Committee (VICC), these 
precautions are designed to “minimize transmission of zoonotic pathogens from animals to 
veterinary personnel in private practice” (Elchos et al., 2008, p. 417).  Updated every two years 
and based on NASPHV VICC expertise, current research-based scientific evidence and input 
from consultants to the committee, the Compendium is a valuable document that helps to reduce 
the occupational hazards faced by veterinary personnel (J. Scheftel, Personal Communication, 
February 18, 2010; D. Dvorak, Personal Communication, February 23, 2010).  The Compendium 
primarily focuses on the health and safety of veterinary personnel at risk of zoonotic disease 
exposure and offers detailed information on veterinary standard precautions, protective actions 
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during veterinary procedures, environmental infection control, employee health and infection 
control plans (D. Dvorak, Personal Communication, February 23, 2010).    
Unfortunately, the Compendium in its entirety is not adaptable for use by an industry outside 
private veterinary practices, such as the equine industry, because it is specifically written for a 
particular population and within a narrow scope (J. Scheftel, Personal Communication, February 
18, 2010).  Furthermore, while there is some guidance for the equine industry in the form of 
MRSA information and fact sheets, there is currently no known extensive document or protocol 
in place that is championed by an experienced, expert committee which offers detailed 
precautionary measures and infection control plans capable of sufficiently reducing and/or 
preventing zoonotic disease transmission for general equine personnel (S. Weese, Personal 
Communication, February 12, 2010).  Thus, there is a gap in this line of research and negative 
health outcomes can result from this deficiency.  This research gap, however, can potentially be 
closed through the development of standard precautionary measures and infection control plans 
that minimize the risk of MRSA infection in equine settings such as professional hunter/jumper 
show jumping competitions, horse racing tracks, polo matches, horseback riding lesson and 
boarding facilities and personal horse farms.   
A document similar in scope and sequence to the Compendium, yet focused on the health and 
safety of equine personnel in settings outside veterinary practice, is needed to provide guidance 
to minimize disease and injury among humans and horses and to reduce the impact of infection 
now and in the future.  Creation and implementation of a document that is targeted towards 
MRSA prevention in general equine personnel, however, is complicated and will require the 
involvement of a committee of people comprised of prominent equine industry leaders, 
experienced MRSA researchers, experts with significant knowledge of MRSA in horses, and 
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equine farm infection control specialists (S.Weese, Personal Communication, February 12, 2010; 
J. Scheftel, Personal Communication, February 18, 2010).  According to Dr. Scott Weese, 
Associate Professor in the Department of Pathobiology at the University of Guelph, Public 
Health and Zoonotic Disease microbiologist for the University's Centre for Public Health and 
Zoonoses, and Chief of Infection Control at the Ontario Veterinary College Teaching Hospital, 
in order for a document that focuses on minimizing the transmission of MRSA between horses 
and humans to be successful and gain industry acceptance, it must be developed by a committee 
of experts that have exposure in the equine industry and have the power to create buy in from 
relevant equine industry groups (Personal Communication, February 12, 2010).   
 Given that such a committee is not currently in place, resources and access to MRSA experts 
is limited, industry buy-in has yet to be established and the tight timeline of this specific project, 
it is not reasonable or appropriate at this time to generate a document that is similar to the 
Compendium for the equine industry (J. Scheftel, Personal Communication, February 18, 2010; 
S. Weese, Personal Communication, February 12, 2010).  However, the entire Compendium and 
all of its underlying components are related to public health and many of the preventative 
measures suggested within the document, as well as the model infection control plan made 
available in its appendix, can be used outside of veterinary clinics (J. Scheftel, Personal 
Communication, February 18, 2010; D. Dvorak, Personal Communication, February 23, 2010).  
According to Compendium co-chair Joni Scheftel, DVM, MPH, DACVPM and Compendium 
committee consultant, Glenda Dvorak, DVM, MPH, preventative measures are relatively 
universal and the personal protective actions, personal protective equipment, cleaning and 
disinfection of equipment, and environmental surfaces sections of the Compendium, as well as 
the written infection control plan, can potentially be modified for the equine industry and 
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applicable to horse events and equine farm settings (J. Scheftel, Personal Communication, 
February 18, 2010; D. Dvorak, Personal Communication, February 23, 2010).   
However, for these modifications to occur, additional research must first be conducted to 
understand the Compendium and its current functional status in veterinary practice.  Likewise, it 
is necessary to complete a thorough analysis of the weaknesses and strengths of the Compendium 
in order to move the document forward and assess the practicality of using it as a template for the 
equine industry.  Further examination and assessment of the Compendium will reveal any 
deficiencies in the document and help guide future modifications.  This assessment will make it 
possible to alter the Compendium for use as a control mechanism in the equine industry, if 
applicable.  Synthesis of this information will facilitate the formation of policy implications 
relevant to this line of research and structure the development of recommendations for future 
actions and study.            
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 Project Purpose, Goals and Expectations 
Purpose of the Project 
Veterinarians, public health practitioners, and infectious disease specialists all suggest that 
standard precautionary measures and an infection control plan are needed for equine industry 
areas outside of veterinary practices to reduce the zoonotic and reverse zoonotic transmission of 
MRSA and guide practices if an outbreak were to occur (D. Dvorak, Personal Communication, 
Februaru 23, 2010; J. Scheftel, Personal Communication, February 18, 2010; S. Weese, Personal 
Communication, February 12, 2010).  Likewise, these experts support the development of a 
MRSA brochure that outlines the pertinent information regarding transmission control so that 
those in the equine industry have a readable and easily accessible document that summarizes 
their role in protecting themselves and their horses from disease (D. Dvorak, Personal 
Communication, February 23, 2010; J. Scheftel, Personal Communication, February 18, 2010; S. 
Weese, Personal Communication, February 12, 2010).  However, these suggested interventions 
will most likely be an end result of additional and complex research that is beyond the scope of 
this particular project (Weese, Personal Communication, February 12, 2010).  Therefore, the 
purpose of this project is to first identify and thoroughly investigate a zoonotic disease control 
document (the Compendium) that can potentially be used as a template for the equine industry.  
This is to be followed by an examination of the existing knowledge regarding MRSA in horses 
and transmission of the bacterium between horses and humans.  Connecting existing knowledge 
on MRSA in horses with a zoonotic disease control template will not only serve as a mechanism 
to raise awareness, but will act as a stepping stone for future research.  The expert opinions and 
consultations with practicing veterinarians, as well as the wealth of MRSA research in the 
literature, guided this project and fostered its development.   
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The main focus of this project is to start the process of providing reasonable guidance for 
minimizing MRSA colonization, infection and disease among people in equine settings by better 
understanding the Compendium and its functional status in veterinary practice.  Understanding 
the current capacity of the Compendium, its strengths and weaknesses, and its potential for use as 
a template for the equine industry can make it clear exactly what is needed to move this 
document forward in the future.  Assessment of the Compendium and synthesis of findings, 
combined with background research on equine MRSA and existing information from experts, 
will set up a situation in which it is possible to better understand what is needed to meet equine 
industry needs and to judge whether the Compendium is capable of meeting those needs.  Future 
development and dissemination of new (or modification of existing) control mechanisms 
targeted toward the equine industry specifically will improve health and hygiene not only among 
horses and their handlers, but in the community as well.  By proliferating guidelines and control 
mechanisms into the equine industry, persons involved in handling horses, competing at horse 
events and residing or interacting on equine farms will be better protected and we will see an 
increase in the practice of precautionary measures and use of infection control plans; which, in 
turn, will reduce the burden of MRSA infection and disease in horses and their handlers and 
improve overall public health in the community.   
Goals of the Project 
Goals of this project include gaining a deeper insight into the zoonotic and reverse zoonotic 
transmission of MRSA and better understanding the Compendium and its application to the 
equine industry.  It is hypothesized that assessment of the Compendium and synthesis of findings 
will result in identification of aspects of the Compendium that are feasible for use in the equine 
industry.  The public health impact of this project is to begin the process of reducing 
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transmission of equine MRSA between horses and humans and control potential MRSA 
outbreaks in the industry by first establishing if a modified version of the Compendium is an 
appropriate document that is available for use as a template for the equine industry.  If so, an 
additional goal of this project is to outline the potential policy implications associated with these 
modifications and determine what is needed to move the Compendium forward in the equine 
industry.  It is predicted that this preliminary research will serve as a mechanism to raise 
awareness and foster the development of precautionary measures and an infection control plan 
specific to the equine industry.  This will, in turn, improve overall health in the human and 
equine population and reduce risk of infection by enhancing ability to practice appropriate safety 
measures.    
Expectations and Outcomes of the Project 
Based on the need for preventative guidelines specific to the equine industry, the products of 
this project include gaining a better understanding of equine MRSA and horse to human 
transmission, raising awareness of the scope of zoonotic disease risk in equine settings, 
addressing the development and current performance of the Compendium, establishing the 
practicality and benefit of using the Compendium as a template for the equine industry, and 
providing a sample of potential Compendium modifications that are practical and effective in 
reducing the risk of MRSA infection among horses and handlers actively involved in the equine 
industry.   
The overarching expectation for this project is that it serves as an initiative to spur interest in 
this considerable public health concern.  Once interest is peaked and the importance of this topic 
is realized, those with significant knowledge of MRSA in horses and exposure in the equine 
industry can form a committee and actively champion the development of a comprehensive 
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protocol that successfully minimizes the risk of MRSA transmission between horses and humans 
in equine settings outside private veterinary practices.          
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Background and Significance 
Understanding MRSA Basics  
Methicillin-resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium that is 
commonly carried on the skin or in the nasal passages of approximately 25% to 40% of the 
healthy human population (CDC, 2009a; CDC, 2009b; CDC, 2009c; CDC, 2009d).  It is 
normally a harmless inhabitant of the skin, nares and nasal cavity, but the bacterium can enter the 
body through openings in the skin and cause a range of issues from red, swollen and painful boils 
to serious blood, bone and joint infections (CDC, 2009a; CDC, 2009d).  People become infected 
with MRSA by either (1) coming in physical contact with people or animals who are colonized 
with the bacteria on their body or are already infected, or (2) physically coming in contact with 
objects such as door handles, tables, floors, sinks, towels and other surfaces that have been 
touched by a MRSA colonized or infected person (AVMA, 2009; CDC, 2009a; CDC, 2009d).  
Staphylococcus aureus commonly enters the body through cuts, wounds, abrasions or other 
breaks in the skin (CDC, 2009c).  People with obvious breaks in the skin (lacerations, surgical 
incisions, burns, or skin ulcers), depressed immune systems (infants, elderly, HIV/AIDS patients, 
autoimmune disease patients) and/or chronic diseases (diabetes, heart disease, cancer) have a 
higher risk of developing a MRSA infection as compared to the general public (CDC, 2009c).  
Typically, those carrying MRSA never experience symptoms and are usually unaware that they 
are carriers (CDC, 2009c).  MRSA, however, is easily spread from person-to-person and can 
cause serious problems if it gains access to the body (CDC, 2009c).     
MRSA is a problematic pathogen that causes both nosocomial (hospital-acquired) infections 
and community-acquired infections (infections in healthy people without recent history of 
hospitalization or medical procedures) in humans and is often difficult to treat given its 
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resistance to methicillin and penicillin classes of antibiotics (CDC, 2009b; CDC, 2009c; 
Hanselman et al., 2006; Klevens et al., 2007; Naimi et al., 2003; Weese et al., 2005a).  
Community-acquired MRSA (CA-MRSA) infections typically present as skin and soft tissue 
infections that frequently take on the form of boils, abscesses, cellulitis, carbuncles (infections 
larger than abscesses and with several openings to the skin), sty and impetigo (pus-filled blister 
skin infections) (CDC, 2009c; Naimi et al., 2003).  CA-MRSA risk factors include frequent 
contact with other people in crowded areas, contact with contaminated surfaces and shared items, 
poor hygiene and compromised skin (CDC, 2009c; Naimi et al., 2003).  Currently, MRSA strain 
USA 300 is the most common CA-MRSA strain in humans (CDC, 2009c; Naimi et al., 2003).   
Conversely, hospital-acquired MRSA (HA-MRSA) infections occur in individuals in 
hospitals and healthcare centers (CDC, 2009b; Klevens et al., 2007).  These types of infections 
most commonly affect people with compromised immune systems (CDC, 2009b; Klevens et al., 
2007).  HA-MRSA risk factors include hospitalization, surgery, indwelling devices, prolonged 
antibiotic therapy, frequent visits to out-patient facilities, long-term hospital care, dialysis, and 
history of MRSA infections (CDC, 2009b; Klevens et al., 2007).  MRSA transmission in the 
hospital setting is often through intermediate hand carriage by colonized or infected individuals 
(CDC, 2009b; Klevens et al., 2007).  HA-MRSA infections comprise the majority of all 
clinically significant MRSA infections and are associated with MRSA strain USA 100 (CDC, 
2009b; Klevens et al., 2007).  Some strains of MRSA are able to not only spread from person-to-
person, but from hospital-to-hospital (CDC, 2009b).  These strains are known as epidemic 
MRSA (EMRSA) and occur when patients or staff travels between hospitals (CDC, 2009b).     
MRSA surfaced worldwide in healthcare settings after the introduction of Methicillin in the 
early 1960s (CDC, 2009b; Cuny et al., 2008; Weese, 2005; Voss & Doebbeling, 1995).  It 
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became endemic in many countries by the mid-1970s (Voss & Doebbeling, 1995; Weese, 2005).  
Resistant to beta-lactam antibiotics and a wide range of other antimicrobial classes, MRSA is 
associated with increased morbidity and mortality and is considered one of the most important 
hospital-associated pathogens in human medicine (Anderson et al., 2008; CDC, 2009b; Cuny et 
al., 2008; Maree et al., 2007; Weese et al., 2005a).  Since MRSA is strongly linked with hospitals 
and health care units, it has traditionally been regarded as a hospital acquired organism (AVMA, 
2009; CDC, 2009b; Leonard & Markey, 2008; Weese, 2005a).  However, there has been a shift 
in the epidemiology of MRSA infection and community-associated forms of MRSA have 
become more common during the past decade (AVMA, 2009; CDC, 2009c; Cuny et al., 2008; 
Gorwitz et al., 2008; Hanselman et al., 2006; Klevens et al., 2006; Weese et al., 2005a).   
Research reveals that people with compromised immune systems are more likely to develop 
a MRSA infection, but infections in immunocompetent people in crowded settings such as 
prisons, housing projects, schools and public events are also quite common (CDC, 2009c).  It 
appears that the prevalence of MRSA in humans is on the rise not only in the hospital setting 
(62% infection increase in intensive care units between 1974 and 2004), but in the community as 
well (AVMA, 2009; CDC, 2009b; CDC, 2009c; Cuny et al., 2008; Hanselman et al., 2006; 
Leonard & Markey, 2008; Weese et al., 2005a).  Moreover, it is important to note that 
researchers attribute the increasing prevalence of CA-MRSA in humans over the past 10 years, 
in part, to zoonotic sources (Baptiste et al., 2005; Khanna et al., 2007; Leonard & Markey, 2007; 
Maree et al., 2007; O’Mahony et al., 2005; Seguin et al., 1999; van Duijkeren et al., 2004; Voss 
et al., 2005; Weese et al., 2005a; Weese et al., 2005b; Witte et al., 2007).  MRSA has the ability 
to cross species barriers and it is now evident that animals can serve as MRSA reservoirs and 
become colonized and infected (AVMA, 2009).  MRSA is evolving and expanding into a 
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worldwide public health problem that is threatening human and animal health (AVMA, 2009; 
CDC, 2009d).       
Evolution of MRSA 
 Extensive antibiotic use in food animal production and medicine has been linked to the 
evolution of drug-resistant pathogens like MRSA (Leonard & Markey, 2007; Mathew, Cissell & 
Liamthong, 2007; USDA-APHIS, 2007).  MRSA strains are resistant to the beta-lactam class of 
antibiotics (USDA-APHIS, 2007).  This class of antibiotics includes penicillin and its 
methicillin, oxacillin, cloxacillin and amoxicillin derivates (USDA-APHIS, 2007).  MRSA 
strains acquire resistance to beta-lactams not by producing penicillin-degrading enzymes, but by 
acquisition of the mecA gene, which expresses a penicillin-binding protein (PBP2a) in the 
bacterial cell wall that has a low affinity for beta-lactam antibiotics (USDA-APHIS, 2007).   
MRSA is most commonly defined by the presence of the mecA gene (gene encoding 
methicillin resistance), which is part of a larger genetic element known as the staphylococcal 
chromosomal cassette mec (SCCmec) (CFSPH, 2006; Leonard & Markey, 2008).  Researchers 
have identified and described five SCCmec types and found that SCCmec type I, II, III and IV 
are widespread across the world (CFSPH, 2006; Leonard & Markey, 2008).  When considering 
the evolution of MRSA, it is most important to understand that the majority of MRSA isolates 
are evolving further and are currently not only resistant to beta-lactam antibiotics, but are also 
resistant to other antimicrobial classes (USDA-APHIS, 2007).  Presently, most hospital-acquired 
MRSA isolates are only susceptible to vancomycin and thus physicians and researchers alike are 
concerned that vancomycin resistance in MRSA will eventually develop and spread in hospitals 
and the community (CFSPH, 2006).   
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Currently, some MRSA strains are able to damage, immobilize or avoid immune system 
responses all together by producing specific virulence factors and toxins, which often leads to 
serious disease and/or death (USDA-APHIS, 2007).  While all strains of Staphylococcus aureus 
can cause infections, some strains can produce exotoxins that cause toxic shock syndrome and 
scaled skin syndrome (CFSPH, 2006).  Other strains are able to produce enterotoxins when in 
food and can cause staphylococcal gastroenteritis (food poisoning) when ingested (CFSPH, 
2006).   
In addition, some Staphylococcus aureus strains carry Panton-Valentine Leucocidin (PVL), 
which can cause tissue necrosis, leukocyte destruction and severe inflammation (CFSPH, 2006).  
Strains that carry PVL have been found in many countries in the form of community-acquired 
MRSA infections (CFSPH, 2006).  PVL-positive MRSA strains have been identified as the root 
cause of outbreaks of serious skin infections and disease among children and young adults and 
have also been associated with clinical disease and severe infections in animals (CFSPH, 2006).  
This evolution of multi-drug resistant forms of MRSA makes treatment extremely difficult and 
often forces physicians to prescribe new or experimental drugs to combat the pathogen (USDA-
APHIS, 2007).       
Typing of MRSA 
 The increasing prevalence of MRSA in human and animal populations has prompted 
researchers to conduct epidemiologic studies and investigate the genetic differences among 
strains of the bacterium (Anderson, Lefebvre, & Weese, 2008; Farr, B.M., 2004; Leonard & 
Markey, 2008).  To date, numerous MRSA strains have been identified based on the genetic 
analysis of the bacteria (Anderson, Lefebvre, & Weese, 2008; AVMA, 2009; CDC, 2009a; Farr, 
B.M., 2004; Leonard & Markey, 2008; Weese, 2007a).  Typing and naming of MRSA strains is 
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key to understanding how this organism is spreading and why infection rates are growing 
(Anderson, Lefebvre, & Weese, 2008; Farr, B.M., 2004; Leonard & Markey, 2008; Weese, 
2007a).  However, a standard MRSA typing method has yet to be adopted and the nomenclature 
of MRSA strains varies worldwide, which confounds epidemiologic study results and 
complicates tracking of particular MRSA strain incidence rates in specific populations and 
period prevalence (Anderson, Lefebvre, & Weese, 2008; AVMA, 2009; CDC, 2009a; Farr, 
B.M., 2004; Leonard & Markey, 2008; Weese, 2007a).  Without a universal method for typing 
and naming MRSA strains, one specific genetic strain of MRSA may carry several different 
names depending on the location in which the strain was found and the typing method used to 
identify it (AVMA, 2009; Weese, 2007a).   
Currently, both phenotypic and molecular methods can be used to type MRSA strains in 
humans and animals (Anderson, Lefebvre, & Weese, 2008; AVMA, 2009; Farr, B.M., 2004; 
Leonard & Markey, 2008).  Traditional phenotypic methods include the use of colonial 
characteristics, antibiotic susceptibility patterns, biochemical reactions, susceptibility to various 
phages, and toxin production (Anderson, Lefebvre, & Weese, 2008; AVMA, 2009; Farr, B.M., 
2004; Leonard & Markey, 2008).  Molecular typing methods include pulsed field gel 
electrophoresis (PFGE), multilocus sequence typing (MLST), SCCmec typing, and spa typing 
(Anderson, Lefebvre, & Weese, 2008; AVMA, 2009; Farr, B.M., 2004; Leonard & Markey, 
2008).   
Presently, molecular typing methods are preferred over traditional phenotypic methods 
because they are useful in the investigation of outbreaks and documentation of animal-to-human 
and human-to-animal transmission (Anderson, Lefebvre, & Weese, 2008; Farr, B.M., 2004; 
Leonard & Markey, 2008).  However, in order to supplement phenotypic and molecular 
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methods, a new Staphylococcus aureus typing method was recently developed (Anderson, 
Lefebvre, & Weese, 2008; AVMA, 2009; Farr, B.M., 2004; Leonard & Markey, 2008).  This 
method uses several variable number tandem repeat (VNTR) sequences to type animal MRSA 
isolates (Anderson, Lefebvre, & Weese, 2008; AVMA, 2009; Farr, B.M., 2004; Leonard & 
Markey, 2008).  Researchers suggest that VNTR typing can accurately discriminate strains and 
can trace the origin of outbreaks in both epidemic and endemic settings (Leonard & Markey, 
2008).  Unfortunately, published data on VNTR typing of animal MRSA isolates is unavailable 
at this time (AVMA, 2009; Leonard & Markey, 2008). 
In humans, typing of MRSA strains is often followed by sub-categorization into either 
community-associated or hospital-associated infection groups, despite the complexities that 
accompany this distinction (Weese, 2007a).  Given that HA-MRSA and CA-MRSA infections 
have contrary genetic characteristics and susceptibilities, practicing physicians are better able to 
understand, treat and mange MRSA when they are separated into these two broad classes (CDC, 
2009a).  However, comparing this situation to horses is not practical or advantageous, as there 
are several characteristics that separate MRSA in horses versus MRSA in humans, according to 
Dr. Scott Weese (Weese, 2007a).  For example, the types of MRSA found in horses are different 
from the types of MRSA found in humans (Weese, 2007a).  Reports of MRSA in horses most 
often involve one family, or one clone, of MRSA (Weese, 2007a).  This family of MRSA is 
referred to as USA 500, Canadian epidemic MRSA5, Sequence Type 8 (ST8) and/or Clonal 
Complex 8, depending on where the bacterium surfaces geographically and the typing method 
used to identify it (Weese, 2007a).   
While this particular MRSA strain is recognized in the human population, it is uncommon in 
people (Weese, 2007a).  According to Dr. Weese, this strain is better adapted for survival in 
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horses and tends to differ from common community-acquired and hospital-acquired strains in 
humans, which is in contrast to small animal strains that are often indistinguishable from human 
strains (Leonard & Markey, 2008; Weese, 2007a).  What is troubling about this strain is that it is 
unique to horses, but it has been found in humans and is capable of surviving and thriving in 
both species, which suggests that MRSA in horses is not necessarily a human-borne disease 
(Weese, 2007a).  According to researchers, most small animal species presumably acquire 
MRSA from contact with humans, while certain MRSA strains are of equine origin and have 
adapted to more than one mammalian species (Walther, 2009).  This means that transmission 
between humans and horses is a prominent aspect of concern, especially since this particular 
equine MRSA strain has been reported in both North America and Europe and is most likely 
widespread internationally (Weese, 2007a).                
Epidemiology of MRSA in Humans 
According to the Centers for Disease Control and Prevention (CDC), MRSA is a major 
pathogen that is affecting humans worldwide (CDC, 2009c).  In the United States, MRSA has 
been identified as one of the most common causes of skin and soft tissue infections in people 
(CDC, 2009c).  Humans often carry MRSA in the anterior nares, but other carriage sites include 
the skin, throat, axilla, perineum and groin (Leonard & Markey, 2008).  It is presumed that as 
many as 60% of the healthy human population carries MRSA intermittently, while 
approximately 20% of people persistently carry a single strain (Leonard & Markey, 2008).  
However, carriage rates tend to vary depending on the population studied and geographic areas 
(Leonard & Markey, 2008).  For example, adult carriage rates are often lower than the carriage 
rates of children and prevalence of Staphylococcus aureus isolates in Southern and Western 
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Europe exceed 40% while isolates in Northern Europe are less than 1% (Leonard & Markey, 
2008; Tiermersma et al., 2004). 
In recent decades, MRSA rates have increased dramatically worldwide (Leonard & Markey, 
2008).  From 1975 to 1991, MRSA prevalence among all hospital Staphylococcus aureus 
isolates increased by roughly 27% in the United States (Panlilio et al., 1992).  The proportion of 
MRSA isolates from patients in intensive care units increased by approximately 24% in the 
United States between 1992 and 2003 (Klevens et al., 2006).  A report published by Gorwitz et 
al. in 2008 estimated that about 4.1 million people in the United States population are colonized 
with MRSA (Gorwitz et al., 2008).  In England and Wales, the proportion of Staphylococcus 
aureus bacterium due to MRSA increased by approximately 39% between 1992 and 2000 
(Johnson et al., 2001).   
Researchers also believe that community-acquired MRSA rates are on the rise nationally and 
internationally, but tracking CA-MRSA prevalence rates is difficult given the varying CA-
MRSA definitions used in research and the different locations in which studies are conducted 
(Leonard & Markey, 2008).  It is also important to understand that MRSA infections cause 
substantial illness and thus are a contributing factor to the rise in health care costs (Leonard & 
Markey, 2008).  Researchers estimate that 125,969 hospitalizations with a MRSA diagnosis 
occur annually in the United States and the resultant costs of these events are exorbitant 
(Kuehnert et al., 2005).  
 Understanding MRSA in Animals 
Until a report of a MRSA mastitis infection in a dairy cow in 1972, MRSA was considered 
solely a human pathogen that was mainly confined to health-care settings (Devriese, Van 
Damme & Fameree, 1972).  However, it has now become evident that MRSA is an aggressive 
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pathogen that concerns both humans and animals (Anderson et al., 2008; Baptiste et al., 2005; 
Hanselman et al., 2006; Huijsdens et al., 2006; Lee, 2003; Morris et al., 2006; Tomlin et al., 
1999; Vitale, Gross & Weese, 2006; Weese, 2005; Weese et al., 2005a; Weese et al., 2005b; 
Wulf et al., 2006; Yasuda et al., 2000).  Current research reports that MRSA colonization and 
infection in domestic animals are occurring frequently (Anderson et al., 2008; Baptiste et al., 
2005; Hanselman et al., 2006; Huijsdens et al., 2006; Lee, 2003; Morris et al., 2006; Tomlin et 
al., 1999; Vitale, Gross & Weese, 2006; Weese, 2005; Weese et al., 2005a; Weese et al., 2005b; 
Wulf et al., 2006; Yasuda et al., 2000).  In addition, an ample amount of research details the 
transmission of MRSA between humans and horses, dogs, cats, pet birds, cattle and pigs 
(Anderson et al., 2008; Baptiste et al., 2005; Hanselman et al., 2006; Huijsdens et al., 2006; 
Lee,2003; Morris et al., 2006; Tomlin et al., 1999; Vitale, Gross & Weese, 2006; Weese, 2005; 
Weese et al., 2005a; Weese et al., 2005b; Wulf et al., 2006; Yasuda et al., 2000).  
Presently, MRSA is not only recognized as a hospital-associated pathogen, but as a 
community-associated, veterinary and zoonotic pathogen of concern (Anderson et al., 2008; 
Baptiste et al., 2005; Hanselman et al., 2006; Huijsdens et al., 2006; Lee,2003; Morris et al., 
2006; Tomlin et al., 1999; Vitale, Gross & Weese, 2006; Weese, 2005; Weese et al., 2005a; 
Weese et al., 2005b; Wulf et al., 2006; Yasuda et al., 2000).  What is more, according to 
researchers, community associated MRSA (CA-MRSA) in humans is a contributing factor in the 
increase in MRSA infection in companion animals (Baptiste et al., 2005; Hanselman et al., 2006; 
Huijsdens et al., 2006; Weese, 2005). 
MRSA Transmission between Humans and Animals    
For many years, MRSA transmission was thought to occur solely from human to animal 
(AVMA, 2009).  Transmission was typically occurring between the hands of the human and the 
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nostrils of the animal (AVMA, 2009).  However, emerging research has uncovered that MRSA 
can be transmitted from an animal to a human (zoonotic) and from a human to an animal (reverse 
zoonotic) (AVMA, 2009).  If an animal is exposed to MRSA and becomes colonized, he/she can 
serve as a MRSA reservoir and transmit the infection to other animals and to human handlers 
(Baptiste et al., 2005; Hanselman et al., 2006; Huijsdens et al., 2006; Manian, 2003; Weese, 
2005).  It is important to note that seemingly healthy animals may carry MRSA without 
exhibiting symptoms and thus pose a risk to handlers (Huijsdens et al., 2006; Yasuda et al., 
2000).  This has been documented in veterinary clinics and hospitals, on personal farms and in 
slaughterhouses, as well as in health care settings and in the community (de Neeling et al., 2007; 
Manian, 2003; Seguin et al., 1999; Weese et al., 2005a; Weese et al., 2005b; Weese & Rousseau, 
2005).  Moreover, data indicates that people who do come in contact with MRSA colonized or 
infected animals may become colonized and infected themselves (AVMA, 2009).  Thus, animals 
and humans will transfer MRSA infection when they come in contact with each other (Lloyd, 
2006; Oehler et al., 2009; Weese, 2005).  Furthermore, until an animal is free of infection, re-
transmission can occur and animals and humans can remain at risk (Baptiste et al., 2005; 
Manian, 2003; Tomlin et al., 1999).  
MRSA in Humans Who Interact with Animals 
Recent research has made it evident that humans who interact frequently with certain animals 
are at a relatively high risk of contracting MRSA as compared to those who do not encounter 
animals on a routine basis (Baptiste et al., 2005; Khanna et al., 2007; Leonard & Markey, 2007; 
O’Mahony et al., 2005; Seguin et al., 1999; van Duijkeren et al., 2004; Voss et al., 2005; Weese 
et al., 2005a; Weese et al., 2005b; Witte et al., 2007).  MRSA cases in companion and food 
animals have grown rapidly over the past 10 years and researchers have seen a spike in MRSA 
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colonization and MRSA infections among farmers, veterinary personnel, pet owners, and animal 
handlers (Baptiste et al., 2005; Khanna et al., 2007; Leonard & Markey, 2007; O’Mahony et al., 
2005; Seguin et al., 1999; van Duijkeren et al., 2004; Voss et al., 2005; Weese et al., 2005a; 
Weese et al., 2005b; Witte et al., 2007).  Researchers attribute the increase in MRSA infections 
among those who interact with animals specifically, as well as the rising prevalence of MRSA in 
humans in general, partly to community associated and zoonotic sources (Baptiste et al., 2005; 
Khanna et al., 2007; Leonard & Markey, 2007; Maree et al., 2007; O’Mahony et al., 2005; 
Seguin et al., 1999; van Duijkeren et al., 2004; Voss et al., 2005; Weese et al., 2005a; Weese et 
al., 2005b; Witte et al., 2007).   
Research has documented MRSA colonization and infection among people who handle 
swine, cattle, dogs, cats, horses and zoo animals (AVMA, 2009).  Cases of MRSA transmission 
between these animals and their human associates have also been reported (AVMA, 2009).  Most 
notable, however, are recent studies that have suggested that pig farmers (Armand-Lefevre et al., 
2005; Voss et al., 2005), veterinary personnel (Leonard & Markey, 2008; O’Mahony et al., 2005; 
Sequin et al., 1999; Weese et al., 2005a; Weese et al., 2005b; Weese et al., 2006a) and equine 
workers (Leonard & Markey, 2008; O’Mahony et al., 2005; Sequin et al., 1999; Weese et al., 
2005a; Weese et al., 2005b; Weese et al., 2006a) are at considerably high risk of being MRSA 
reservoirs.   
Voss, Loeffen, Bakker, Klassen and Wulf (2005) surveyed pig farmers in the Netherlands 
and found that 23% of the farmers were colonized with MRSA.  This colonization rate among 
the pig farmers was 760 times higher than the colonization rate among the general Dutch 
population (Voss et al., 2005).  In a similar study, Khanna, Friendship, Dewey and Weese (2008) 
surveyed 20 Ontario pig farms and found that MRSA colonized pigs were present on 45% of the 
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farms.  In this recent study, the overall prevalence of MRSA in pigs was 25% and the MRSA 
carriage rate among the pig farmers reached 20% (Khanna et al., 2008).  Interestingly enough, 
individuals residing on farms where MRSA was detected in pigs were more likely to be 
colonized themselves, whereas people on farms without colonized pigs tested negative for the 
bacterium (Khanna et al., 2008).  In addition, where MRSA was detected, similar MRSA strains 
(ST398 and USA100) were found in both the pigs and their handlers, leading researchers to 
suggest that this particular clone of MRSA may be especially capable of colonizing pigs and 
people and transferring easily between the species (Khanna et al., 2008).    
Cuny, Stanek, Strommenger, and Witte (2008) conducted a study of horses admitted to the 
Vienna Veterinary University Hospital between 2006 and 2007.  Of the 140 horses with wound 
infections (either as a result of surgery or wounded upon admission), 25 of them tested positive 
for MRSA (Cuny et al., 2008).  Clusters of the same MRSA strains were found in horses residing 
together in the same clinical department of the hospital at the same time, suggesting nosocomial 
transmission (Cuny et al., 2008).  Researchers proceeded to obtain nasal swabs from the 
veterinary and support staff that came in contact with the infected horses (Cuny et al., 2008).  Of 
the 131 individuals tested, 18 were positive for MRSA (Cuny et al., 2006).  The researchers were 
unable to determine whether the infections in the horses resulted from an outside source or from 
transmission from the veterinary and support staff (Cuny et al., 2006).  However, the clusters of 
MRSA strains obtained from the horses and humans, while encompassing all different strains, 
appeared in both species, indicating that the bacterium crossed barriers and infection occurred 
because of contact between the veterinary staff and the horses (Cuny et al., 2006).   
Weese, Archambault, Willey, Hearn, Kreiswirth, Salid-Salim, McGeer, Likhoshvay, Prescott 
and Low (2005a) investigated MRSA colonization rates in horses and horse personnel at the 
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Ontario Veterinary College – Veterinary Teaching Hospital (OVC-VTH).  The researchers also 
cultured a randomly selected group of horses and persons on farms in southern Ontario (Weese 
et al., 2005a).  Between October 2000 and November 2002, a total of 79 horses and 27 persons 
were found to be colonized or infected with MRSA (Weese et al., 2005a).  Equine isolates were 
recovered from both the OVC-VTH and personal horse farms, with 27 of the equine isolates 
from the veterinary hospital and 41 from a single thoroughbred farm in Ontario (Weese et al., 
2005a).  Of the total 27 human isolates, 17 were from the veterinary hospital and 8 were from the 
thoroughbred farm (Weese et al., 2005a).  A total of 13 horses and 1 person were found to be 
clinically infected with MRSA (Weese et al., 2005a).  The researchers concluded that MRSA 
infection is not only a problem in the veterinary hospital setting, but on equine farms as well 
(Weese et al., 2005a).  According to the researchers, further study and discussion is needed to 
clarify the role of MRSA in equine disease and better understand the transmission of this 
pathogen between horses and humans (Weese et al., 2005a).                       
MRSA in Companion Animals (Dogs and Cats) 
Mann (1959) suggested years ago that companion animals such as dogs and cats could be a 
source of zoonotic staphylococcal infections in humans.  Recent research has verified that 
companion animals are indeed a source of MRSA infections in humans and that the MRSA 
isolates from dogs and cats are often indistinguishable from the most common HA-MRSA 
strains in the human population (Faires et al., 2010; Manian, 2003; O’Mahony et al., 2005).  
Studies conducted in Europe found matching strains of MRSA in cats, dogs and veterinary staff 
(Baptiste et al., 2005; O’Mahony et al., 2005).  A Canadian study also discovered identical 
MRSA isolates in infected pets and their owners (Weese et al., 2006a).  According to 
researchers, human MRSA strains are predominant in household pets (Faires et al., 2010; 
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Leonard & Markey, 2008; Weese et al., 2006a).  This suggests that companion animals most 
likely become colonized with MRSA via contact with colonized or infected people (Faires et al., 
2010; Leonard & Markey, 2008; Weese et al., 2006a).  Colonized or infected companion animals 
such as dogs and cats can then transmit MRSA back to their human handlers or to other species 
(Faires et al., 2010; Leonard & Markey, 2008; Weese et al., 2006a).   
Researchers in Ireland conducted a study that investigated the prevalence of MRSA 
colonization among non-clinically infected dogs admitted to veterinary clinics and veterinary 
referral hospitals (Abbott et al., 2006).  A 0.6% prevalence of MRSA colonization was found in 
non-clinically infected dogs admitted to veterinary clinics and a 0.9% prevalence of MRSA 
colonization was detected among non-clinically infected dogs admitted to a veterinary referral 
hospital (Abbott et al., 2006).  LeFebvre and Weese (2009) conducted a study in Ontario, Canada 
of 26 pet therapy dog handler teams that visited either acute care or long-term care facilities.  
Twelve teams visited acute care facilities and 14 teams visited long-term care facilities 
(LeFebvre & Weese, 2009).  Before each visit to the facilities, the forepaws and haircoat of the 
dogs were swabbed for bacteria and results were recorded (LeFebvre & Weese, 2009).  Hand 
hygiene for each human handler was also recorded during each visit (LeFebvre & Weese, 2009).  
Prior to visitation of healthcare facilities, MRSA or Clostridium difficile (Gram-positive bacteria 
that causes diarrhea and other intestinal disease) was not detected on the paws of any of the 
therapy dogs, nor was it detected on the skin of any of the handlers who were in contact with the 
dogs (LeFebvre & Weese, 2009).  After visitation to the acute care facilities, 4% of the dogs 
acquired Clostridium difficile on their paws (LeFebvre & Weese, 2009).  After handling the dogs 
that had visited the long-term facilities, MRSA was detected on the hands of the investigators 
(LeFebvre & Weese, 2009).  Thus, the investigators concluded that these results suggest that 
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dogs may become infected with MRSA, as well as other pathogens, during visits to healthcare 
facilities (LeFebvre & Weese, 2009).  Moreover, the results highlighted the importance of good 
hand hygiene for practitioners and animal handlers before and after interactions with dogs 
(LeFebvre & Weese, 2009). 
A recent study by Loeffler, Pfeiffer, Lloyd, Smith, Soares-Magalhaes and Lindsay (2010) 
provides further evidence that pets are involved in the transmission of MRSA.  This study, 
conducted in the United Kingdom, identified animals that were carrying MRSA or Methicillin-
susceptible Staphylococcus aureus (MSSA) and then tested the veterinary staff and pet owners in 
contact with the animals (a total of 608 people) (Loeffler et al., 2010).  Of the veterinarians that 
treated MRSA-infected animals, 12.3% were identified as MRSA carriers (Loeffler et al., 2010).  
Of the pet owners, 7.5% were identified as MRSA carriers (Loeffler et al., 2010).  The 
researchers, however, were unable to determine whether the humans already carried MRSA and 
passed the bacterium to their pets or whether the infected pets transmitted the bacterium to the 
veterinarians and pet owners (Loeffler et al., 2010).  Regardless of the transmission route, the 
carriage rates among the veterinarians and pet owners were higher than the expected carriage 
rates in the general population (Loeffler et al., 2010).  The strains of MRSA identified in the 
people and pets in the study matched the predominant strains present in UK human hospitals, 
which suggest that MRSA in most pets is acquired from human contact (Loeffler et al., 2010).   
Additional research documents the possibility that until humans and companion animals are 
free of MRSA colonization or infection, re-transmission from animal-to-human, human-to-
animal, animal-to-animal, and human-to-human can occur (Baptiste et al., 2005; Manian, F.A., 
2003; Tomlin et al., 1999).  One particular case study investigated potential dog-to-human 
transmission of MRSA (Manian. 2003).  A diabetes mellitus patient and his wife battled 
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recurrent MRSA infections and were unable to obtain long-term MRSA decolonization (Manian, 
2003).  Investigators revealed, through a culture of the nares, that the family dog was colonized 
with MRSA (Manian, 2003).  The MRSA infections in the diabetes mellitus patient and his wife    
did not subside until the suspected source, the MRSA colonized family dog, was treated 
(Manian, 2003).  While long-term decolonization for the couple did not occur until after the dog 
was treated, researchers were unable to clearly prove that the dog was the source of the infection 
(Manian, 2003).  However, it is suspected that the couple and the dog repeatedly passed the 
bacterium back and forth and until all three subjects were treated, continued zoonotic and reverse 
zoonotic transmission occurred (Manian, 2003).   
Similarly, a case study by Vitale, Gross and Weese (2006) explored the transmission of 
MRSA between a cat and its owner.  The domestic, short-haired cat presented with a history of 
well-demarcated ulcers on the trunk and responded poorly to corticosteroid therapy and 
antimicrobial therapy (Vitale et al., 2006).  The cat’s owner presented with skin abscesses and 
pneumonia (Vitale et al., 2006).  Skin biopsy specimens were collected from the cat and MRSA 
was isolated from the skin lesions (Vitale et al., 2006).  Swabs of the owner’s anterior nares 
identified MRSA and thus both cat and owner were infected with the bacterium (Vitale et al., 
2006).  The isolates detected in the cat and owner were indistinguishable, making it likely that 
MRSA was transmitted between the owner and the cat and not obtained from another source 
(Vitale et al., 2006).  However, as in other studies, researchers were unable to determine if this 
was a case of zoonotic or reverse zoonotic transmission (Vitale et al., 2006).   
 It is important to note that researchers strongly suspect that MRSA in pets is a human-borne 
disease (LeFebvre & Weese, 2009; Loeffler et al., 2010).  While there is reasonable evidence 
that MRSA can be passed between people and pets, concern over MRSA in companion animals 
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and transmission to people should not be overly exaggerated (LeFebvre & Weese, 2009; Loeffler 
et al., 2010). The majority of pets that have MRSA presumably acquire it from close contact with 
humans and thus efforts aimed at controlling MRSA in companion animals should focus on both 
pets and people (LeFebvre & Weese, 2009; Loeffler et al., 2010).  According to researchers, 
reasonable and practical approaches such as proper hygiene and infection control measures can 
reduce the risk of MRSA transmission between people and pets and reduce the burden of MRSA 
in the population (LeFebvre & Weese, 2009; Loeffler et al., 2010).  If MRSA is not controlled in 
people, risks will increase for pets and thus pets will continue to be a source of subsequent 
human infection (LeFebvre & Weese, 2009; Loeffler et al., 2010).                                           
MRSA in Food Animals (Cattle and Swine) 
 Juhasz-Kaszanyitzky, Janosis, Somongyi, Dan, van der Graaf-van Bloois, van  
Duikeren, and Wagenaar (2007) reported on a case of MRSA transmission between cows and 
humans.  The researchers isolated MRSA from cows with inflammation of the udder (subclinical 
mastitis) and from a person that handled the cows (Juhasz-Kaszanyitzky et al., 2007).  The 
person handling the cows was asymptomatic (Juhasz-Kaszanyitzky et al., 2007).  Phenotypic and 
genotypic diagnostic methods revealed that the strains found in the cows and the colonized 
human handler were indistinguishable (Juhasz-Kaszanyitzky et al., 2007).  While the researchers 
could not establish the direction of the transmission (zoonotic or reverse zoonotic), they suspect 
that this is the first documented case of MRSA transmission between cows and humans (Juhasz-
Kaszanyitzky et al., 2007).  A few additional cases of MRSA in cattle have been reported (Lee, 
2003; Monecke et al., 2007), but much of the attention on MRSA in food animals is currently 
centered on the swine industry (USDA-APHIS, 2007). 
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 Smith, Male, Harper, Kroeger, Tinkler, Moritz, Capuano, Herwaldt, and Diekema (2009) 
investigated carriage of MRSA among swine and swine farmers in Iowa and Illinois.  The 
researchers swabbed the nares of 299 swine and 20 workers from two different production 
systems (designated Production System A (PSA) and Production System B (PSB)) and tested for 
MRSA colonization (Smith et al., 2009).  The overall prevalence of MRSA colonization was 
70% in swine and 64% in swine workers at Production System A (Smith et al., 2009).  
Interestingly, MRSA was not isolated from any swine or workers at Production System B (Smith 
et al., 2009).  Further study is needed to determine the reasons behind the disparity between the 
two systems, but researchers suspect that the breed of swine in production systems, the sources 
of imported sows and the size of the production systems may play a role (Smith et al., 2009).  
Given that the results show that MRSA colonization of swine is common in one production 
system in the United States, the researchers conclude that agricultural animals such as pigs could 
become a major reservoir for the bacterium, which poses a risk to human and swine health 
(Smith et al., 2009). 
 Additional studies have documented MRSA colonization in pigs and have suggested that pigs 
are a source of infection for farmers and their families (Huijsdens et al., 2006; Voss et al., 2005).  
Studies out of Europe and Canada have found that most swine and human MRSA isolates are 
sequence type 398 (ST398), which implies that this family of MRSA is capable of colonizing 
pigs and transferring to people without much difficulty (Khanna et al., 2007).  In studies 
documenting MRSA cases originating from pigs, researchers have found that when pigs are 
implicated as a source, subsequent human infections are often severe (Ekkelenkamp et al., 2006; 
Khanna et al., 2007; van Loo et al., 2007; Witte et al., 2007).  For example, a recent study in the 
Netherlands found that human admissions to hospitals for MRSA are greater when cases are 
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swine associated, with hospital admissions twice as likely for swine related cases as compared to 
non-swine related cases (van Loo et al., 2007).   
Although studies have not determined the overall prevalence of MRSA in swine and other 
food animals in the United States, research has demonstrated that MRSA has emerged in 
Canadian and European swine herds (de Neeling et al., 2007; Khanna et al., 2007) and specific 
cases have been reported in France and Denmark swine populations, as well as Singapore swine 
populations (Guardabassi et al., 2007; Khanna et al., 2007; Sergio et al., 2007).  Given this 
information and understanding that the international transport of pigs is quite extensive, 
researchers presume that MRSA in the swine population could be widespread in the United 
States (van Loo et al., 2007).  Studies have shown that persons working or living in close 
proximity to pigs have a greater risk of becoming MRSA colonized or infected as compared to 
the general public (Huijsdens et al., 2006; van Loo et al., 2007; Voss et al., 2005).  However, 
additional research is needed to better understand how MRSA in pigs affects public health 
outside high-risk exposure groups (USDA-APHIS, 2007).  Moreover, additional research is 
needed to determine if MRSA is present in U.S. swine herds and to evaluate how MRSA impacts 
swine and human health specifically in the United States (Khanna et al., 2007).  Thus, the U.S. 
pork industry has recently funded research like that of Smith, Male, Harper, Kroeger, Tinkler, 
Moritz, Capuano, Herwaldt, and Diekema (2009) on MRSA in the U.S. swine industry (USDA-
APHIS, 2007). 
MRSA in Food Products 
 The public health significance of transmission of MRSA from animals to humans through 
animal food products has yet to be determined (Lee, 2003; van Loo et al., 2007).  While 
Staphylococcus aureus is a leading cause of food-borne bacterial infections (USDA-APHIS, 
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2007), MRSA specifically appears to be rare in foods (Lee, 2003).  For example, two studies 
investigating MRSA in food products detected the bacteria in less than 1% of all the meat, 
cheese and milk samples tested in the study (Lee, 2003; Normanno et al., 2007).  In addition, Pu, 
Han, and Ge (2008) recently investigated the prevalence of MRSA in meats in Baton Rouge, 
Louisiana.  The researchers tested 120 retail meats from 30 grocery stores and isolated MRSA 
from only five pork samples and one beef sample (Pu et al., 2008).  The MRSA strains identified 
in the meat samples were common human strains (USA300 and USA100), which suggests that 
the source of the bacteria was from humans who handled the meat and not the meat itself (Pu et 
al., 2008).  However, the researchers were unable to determine the original source of the bacteria 
with certainty (Pu et al., 2008).  To date, there are no confirmed cases of MRSA infection in 
humans resulting from ingestion of food products originating from animals (Lee, 2003).  The 
food-borne MRSA outbreaks that have been reported have been caused by infected handlers 
contaminating food products (Jones et al., 2002; Kluytmans et al., 1995).  Contamination by 
infected food handlers can be reduced via pasteurization and proper food handling hygiene 
(Jones et al., 2002; Kluytmans et al., 1995; Pu et al., 2008; van Loo et al., 2007).          
MRSA in Horses 
 Recent evidence suggests that MRSA is an emerging and significant equine medicine 
concern (Weese et al., 2005a; Weese et al., 2005b).  According to researchers, horses may be 
particularly pre-disposed to MRSA colonization and infection (Weese et al., 2005a; Weese et al., 
2005b).  Investigators suspect that this is due to the management of horses and/or the biological 
structure of horses (Weese et al., 2005a; Weese et al., 2005b).  In the late 1990s, case reports or 
case series were the only available accounts of MRSA infections in horses (Anderson & Weese, 
2006).   
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In an early case report of equine MRSA, Hartmann, Trostle, and Klohnen (1997) described a 
post-operative wound infection of a horse in a United States veterinary hospital.  The researchers 
speculated that the MRSA infection in the horse originated from a human source (Hartmann et 
al., 1997).  Seguin, Walker, Caron, Kloos, George, Hollis, Jones and Pfaller (1999) further 
validated the findings by Hartmann and colleagues (1997) by documenting potential human-to-
horse transmission of MRSA in a North American veterinary teaching hospital.  Over a 13 month 
period, the investigators detected MRSA infections in 11 horses and MRSA isolates in three 
veterinary hospital personnel (Sequin et al., 1999).  All the horses developed MRSA infections 
during their stay at the veterinary hospital and samples from the horses were obtained from 
surgical wound and vaccination sites (Sequin et al., 1999).  The researchers hypothesized that the 
equine MRSA infections were the result of handling by colonized personnel, given the fact that 
the MRSA strains isolated from the horses and the personnel were indistinguishable (Sequin et 
al., 1999).   
In a later study by Weese, Rousseau, Traub-Dargatz, Willey, McGeer and Low (2005b), 
community-associated equine MRSA (equine MRSA infections that likely originate on a farm) 
was studied in horses for the first time.  After initially documenting a cluster of MRSA cases at a 
Canadian veterinary teaching hospital (Weese, 2004a; Weese et al., 2004b), researchers decided 
to investigate equine MRSA in the community and later identified MRSA colonized horses on 
personal horse farms that had no veterinary clinic or hospital contact (Weese et al., 2005b).  This 
finding indicated that equine MRSA was not only a veterinary hospital-associated threat, but also 
a community-associated pathogen (Anderson & Weese, 2006; Weese et al., 2005b). 
 The prevalence of equine MRSA seems to vary between regions and among areas within the 
same region (Anderson & Weese, 2006).  For example, a study in the Netherlands investigating 
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the prevalence of MRSA in healthy horses found that 200 clinically normal horses were not 
colonized with MRSA (Busscher et al., 2006).  Likewise, a similar study in Slovenia failed to 
isolate MRSA from a survey of 300 horses (Vengust et al., 2006).  In a study in Atlantic, 
Canada, MRSA colonization was not present in any of the 497 sampled horses (Burton et al., 
2008).  However, sporadic infections and MRSA outbreaks in many countries have been 
reported (Anderson & Weese, 2006; Baptiste et al., 2005; Cuny et al., 2006; Weese et al., 2005a; 
Weese et al., 2005b).   
Weese, Rousseau, Willey, Traub-Dargatz, McGeer and Low (2005b) recorded the nasal 
colonization rates of horses and horse personnel in Ontario, Canada and New York, United 
States.  Nasal swab specimens were collected from 972 horses and 107 personnel from equine 
farms with and without a history of MRSA colonization or infection in horses (Weese et al., 
2005b).  MRSA was isolated from 4.7% of the horses and 13% of the humans (Weese et al., 
2005b).  All MRSA isolates were of the same family (CMRSA-5) and results confirmed that 
colonized horses are present on a variety of farms in New York and Ontario (Weese et al., 
2005b).  In a MRSA frequency study at a veterinary teaching hospital, Weese, Rousseau, Willey, 
Archambault, McGeer and Low (2006c) found that the colonization incidence rate of equine 
MRSA was 27/1000 admissions at one particular Canadian hospital.   
A study with a sample of 110 Belgian, French, Dutch and Luxemburg horses found that 
10.9% of the horses carried MRSA and verified that the bacterium is present in West European 
horses (Van den Eede et al., 2009).  Cuny, Kuemmerle, Stanek, Willey, Strommenger and Witte 
(2006) recorded the MRSA infection rate of equine cases presenting to an Austria veterinary 
teaching hospital and found it to be approximately 4.8 cases per 1,000.   “Regional differences in 
prevalence of equine MRSA are important in risk assessment for MRSA colonization and 
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infection” for both horses and humans (Anderson & Weese, 2006, p.302).  Researchers assert 
that precautions must be taken when moving horses from high-prevalence areas and farms to 
low-prevalence areas and farms in order to curb transmission, colonization and infection in both 
species (Anderson & Weese, 2006).  Recent evidence has confirmed that horses are a reservoir 
for MRSA and research has documented frequent MRSA transmission between horses and 
people, with infections reported in people who work with horses on a regular basis (Anderson & 
Weese, 2006; Weese et al., 2005a; Weese et al., 2006c).   
Researchers in the Netherlands presented a recent study on a MRSA outbreak in the Utrecht 
University veterinary hospital (van Duijkeren et al., 2010).  Numerous horses that underwent 
surgical procedures at the hospital developed MRSA infections over a two year period (2006-
2008) (van Duijkeren et al., 2010).  The researchers identified MRSA in healthy horses and 
clinic personnel and thus closed the hospital and thoroughly disinfected the facility (van 
Duijkeren et al., 2010).  However, after the disinfection process another outbreak occurred (van 
Duijkeren et al., 2010).  Researchers investigated and found that approximately 15% of equine 
clinic personnel were MRSA carriers (less than 0.1% of the Dutch general population carries 
MRSA) and that 9.3% of horses carried MRSA at the time of entry to the clinic (van Duijkeren 
et al., 2010).  Additionally, 43% of horses, after residing in the clinic for five weeks, became 
colonized with MRSA at some time during their stay in the hospital (van Duijkeren et al., 2010).   
The researchers also tested clinic surfaces and found that 53% of environmental surface 
samples were positive for MRSA (van Duijkeren et al., 2010).  This study magnifies the 
complexities of controlling MRSA.  Once people and horses are colonized and/or infected with 
MRSA in an equine setting, the bacterium is difficult to contain and nearly impossible to 
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eradicate.  The hospital at Utrecht University has implemented infection control practices, but is 
still at continual risk of MRSA outbreaks (van Duijkeren et al., 2010).          
A retrospective study of MRSA in horses by Anderson, LeFebvre, Rankin, Aceto, Morley, 
Caron, Welsh, Holbrook, Moore, Taylor and Weese (2010) examined the characteristics of 
clinical MRSA infections in 115 horses admitted to six veterinary teaching hospitals in the 
United States and Canada between 2000 and 2006.  In this study, all of the horses involved had 
clinically diagnosed MRSA infections and the researchers detailed the manifestation of the 
disease (Anderson et al., 2010).  The most important finding from this study was that 
community-acquired and hospital-acquired MRSA infections in the horses were equally 
common, which further proves that MRSA is not solely associated with veterinary hospitals 
(Anderson et al., 2010).  Surgical site infections accounted for 58% of the infections in 
hospitalized horses (Anderson et al., 2010).  Of the community-associated infections (infections 
that originated on farms), skin and soft tissue infections accounted for 29% and joint infections 
accounted for a troubling 18% of the total (Anderson et al., 2010).  Joint infections in horses are 
often severe and, although 84% of the horses with MRSA infections in this study survived, those 
with joint infections were left with debilitating complications (Anderson et al., 2010).  The 
researchers of this study concluded that prompt and proper treatment is the key in managing 
horses with clinical MRSA infections (Anderson et al., 2010).  The researchers also suspect that 
MRSA infections on equine farms may occur more often than in equine hospitals, which 
establishes that there is a need to further evaluate the zoonotic transmission of equine MRSA and 
create ways to prevent infection outside of veterinary practice (Anderson et al., 2010).  While 
equine hospitals can facilitate the spread of MRSA, researchers suspect that a significant portion 
of MRSA-positive horses do not originate in clinics or hospitals, but on personal farms 
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(Anderson et al., 2010; Weese, Personal Communication, February 12, 2010).  Thus, equine 
hospitals and personal horse farms need to access and implement solid infection control 
programs that reduce MRSA transmission between horses, between clinics, between farms and 
between horses and humans (Anderson et al., 2010; Weese, Personal Communication, February 
12, 2010).         
Clinical MRSA infections in horses have been well documented and major outbreaks of 
equine MRSA have been reported in North American veterinary hospitals and on personal horse 
farms (Sequin et al., 1999; Weese, 2004a; Weese et al., 2005a; Weese et al., 2005b; Weese et al., 
2006c).  Equine MRSA infections have also been recorded in the United Kingdom (Baptiste et 
al., 2005), Japan (Anzai et al., 1996; Shimizu et al., 1997), Ireland (O’Mahony et al., 2005) and 
Austria (Cuny et al., 2006).  The most common clinical manifestations of MRSA in horses 
appear to be associated with wound and postoperative infections, as is the situation in most 
companion animals such as a dogs and cats (Leonard, 2006; Leonard & Markey, 2008).  
However, equine strains of MRSA tend to differ from commonly identified human strains, which 
suggests that equine MRSA is not necessarily a human-borne disease and horses are capable of 
frequently transmitting the bacterium to people (O’Mahony et al., 2005; Waller, 2005; Weese, 
2004a; Weese et al., 2004b; Weese et al., 2005a; Weese et al., 2005b).  In North America, the 
vast majority of identified MRSA isolates have been classified using PFGE (Anderson & Weese, 
2006).  Most equine MRSA isolates have been found to be subtypes of Canadian epidemic strain 
CMRSA-5 (AKA British eMRSA5 and USA500), which is uncommon in humans (Anderson & 
Weese, 2006).  Researchers have concluded that this particular strain is well adapted to survival 
in horses and, although rare in humans, is capable of transmitting to and surviving in people as 
well (Anderson & Weese, 2006; Weese et al., 2005a; Weese et al., 2005b).  To date, equine 
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isolates, unlike community-associated isolates in humans, have been found to be PVL negative, 
which makes them resistant to a greater number of antimicrobial agents and a significant cause 
of concern (Anderson & Weese, 2006).   
In a veterinary setting, the principal route of transmission is considered to be the hands of 
veterinary personnel (Leonard & Markey, 2008).  However, in a Canadian study by Weese, 
DaCosta, Button, Goth, Ethier and Boehnke (2004b), MRSA contamination of the veterinary 
hospital environment and on veterinary equipment was found to be widespread.  This finding 
suggests that veterinary equipment and the veterinary environment overall is a potential and 
important source of MRSA infection (Weese et al., 2004b).   In a community setting, the 
principal route of transmission is typically between the hands of the human and the nostrils of the 
horse, but farm equipment, tack, grooming tools and other items found in the barn are also 
potential sources of MRSA infection (AVMA, 2009). Equine MRSA is clearly a problem in 
many areas and it is important to understand that this issue reaches beyond horses and personnel 
in veterinary hospitals and affects the general population (Weese, Personal Communication, 
February 12, 2010).  MRSA is present in the equine population and thus the risk of outbreaks in 
equine and human populations will persist, if precautionary measures and infection control plans 
are not developed, disseminated and strictly followed by those who interact with horses in all 
settings (Weese, Personal Communication, February 12, 2010).                                                         
Clinical Signs of MRSA Infection in Humans and Horses 
The clinical signs, symptoms and illnesses that result from a MRSA infection can range from 
mild to severe.  In humans, clinical signs of MRSA can include skin conditions such as pimples 
and boils, but can also include severe diseases and conditions such as cellulitis, furuncles, 
carbuncles, impetigo and scaled skin syndrome (CDC, 2009c).  Once in the bloodstream, MRSA 
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can cause pneumonia, bacteremia, meningitis, sepsis, pericarditis and toxic shock syndrome 
(CDC, 2009c).  Horses who encounter MRSA are also susceptible to developing clinical signs or 
illness (AVMA, 2009).  Current research concludes that most colonized horses will not develop 
clinical signs because they will eliminate the organism naturally (AVMA, 2009).  However, of 
those animals that do develop clinical signs or illness, postoperative infections, wound 
infections, intravenous catheter site infections, urinary tract infections, pneumonia, and skin and 
ear infections are most commonly reported (AVMA, 2009).  Equine MRSA infections appear to 
be primarily opportunistic and can affect young and old horses (Anderson et al., 2010)   
Clinical MRSA infections in horses can present in a variety of ways and equine MRSA 
infection in the community and hospital horse populations is a problem (Anderson et al., 2010).  
While the overall survival rate of horses with MRSA infections is relatively high (80% - 85% 
depending on the severity of the infection and immune strength of the horse), orthopedic 
infection in horses can have critical consequences (lameness, illness, joint infections, skin and 
soft tissue infections, dissemination of infection to other body sites) and prompt additional 
surgeries and prolonged hospital stays (Anderson et al., 2010; Leonard & Markey, 2008).  What 
is important to remember, however, is the fact that MRSA transmission between horses and 
humans occurs in both directions and thus people who work with horses may be at an increased 
risk of MRSA colonization and infection, which places them at increased risk for all the above 
mentioned conditions (Anderson et al., 2008; Elchos et al., 2008; Hanselman et al., 2006; Seguin 
et al., 1999; Weese et al., 2005a; Weese & Rousseau, 2005; Weese et al., 2008).    
 Diagnosis of MRSA in Horses 
MRSA colonization in horses is typically determined by culture of a nasal swab (Anderson & 
Weese, 2006).  A swab is inserted approximately 8-10 centimeters into a nostril in order to make 
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contact with the nasal mucosa (Anderson & Weese, 2006).  The bacterium is grown in a 
controlled environment and then samples are tested to confirm MRSA (Anderson & Weese, 
2006).  While multi-site colonization likely occurs in horses, a nasal culture swab is usually an 
accurate method to determine MRSA colonization (Anderson & Weese, 2006).  Laboratory 
identification of clinical MRSA infections on areas of the body is also determined by a culture-
based technique (Anderson & Weese, 2006).  The infected area is swabbed and clinical 
specimens are sent to a diagnostic lab (Anderson & Weese, 2006).  The Staphylococcus aureus 
isolates are then tested for methicillin resistance or the presence of PBP2a or mecA (Anderson & 
Weese, 2006).   
Depending on enrichment techniques and confirmation testing procedures, screening for 
MRSA can take 3-7 days (Anderson & Weese, 2006).  In terms of infection control, this 
timeframe is a concern (Anderson & Weese, 2006).  When attempting to control the spread of an 
infectious agent and properly treat infections, time is of utmost importance (Anderson & Weese, 
2006).  Real-time identification techniques (real-time polymerase chain reaction) that cut 
screening time down to 1-2 hours are currently being used in human medicine, but similar 
techniques have not been validated for use in horses and thus rapid diagnosis of MRSA in horses 
is unavailable at this time (Anderson & Weese, 2006).              
Treatment of Clinical MRSA Infections in Horses 
 Horses can present with a variety of clinical infections resulting from MRSA (Anderson & 
Weese, 2006).  Researchers have reported clinical infections ranging from mild soft tissue and 
skin infections to septicemia, bacteremia, pneumonia, septic arthritis, osteomyelitis, surgical-
implant infection, and omphalophlebitis (Anderson & Weese, 2006; Weese et al., 2005a).  
According to experts in the field, a significant problem associated with the emergence of MRSA 
51 
 
is “treatment failure caused by empirical treatment of presumed S. aureus infections with beta-
lactam antimicrobials” (Anderson & Weese, 2006, p. 302).  Often, proper MRSA isolate 
identification through culture and antimicriobial-sensitivity testing is not performed (Anderson & 
Weese, 2006).  Given the presentation of the infection, practitioners administer beta-lactam 
antimicriobials for a presumed S. aureus infection without testing to verify the true nature of the 
bacterium (Anderson & Weese, 2006).  Treatment with beta-lactam antimicrobials “can result in 
a prolonged delay in administration of effective therapy and a subsequent increase in morbidity 
and mortality” (Anderson & Weese, 2006, p. 302).  Currently, it is suggested that proper 
treatment in horses should be primarily symptom specific (Anderson & Weese, 2006).  
Practitioners should attend to the presenting condition as needed and, after verifying the presence 
of MRSA and obtaining antimicrobial-susceptibility testing results, administer a cocktail of 
drugs guided by the susceptibility profile as a last resort (Anderson & Weese, 2006).  Experts 
stress that the “judicious use of antimicrobials in animals and humans is essential in order to 
prevent the spread of MRSA strains that are increasingly resistant to known antimicrobials” 
(AVMA, 2009, p. 10).                                       
 Equine MRSA Prevention and Control Efforts 
 The optimal approach to managing MRSA colonized and clinically infected horses is unclear 
at this time (Anderson & Weese, 2006).  No objective information is currently available to 
adequately guide practices in equine veterinary hospitals or on personal horse farms (Anderson 
& Weese, 2006).  Given the emergence of antimicrobial resistance, researchers, however, have 
made it clear that it is not advantageous to treat horses that do not show signs of infection, nor is 
it useful to decolonize horses (Anderson & Weese, 2006).  Presently, equine MRSA experts posit 
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that controlling the spread of this pathogen in clinic and farm settings is contingent on the strict 
application of infectious disease control measures (Anderson & Weese, 2006).   
Since MRSA can be transmitted by both equine and human carriers, it is likely that infection 
control practices such as barrier precautions, hand hygiene, MRSA-colonization screenings, and 
disinfection of contaminated equipment are fundamental for reducing transmission (Anderson & 
Weese, 2006).  Further investigation is needed to “identify if there are particularly high-risk 
contacts between horses and people that can be avoided” altogether (Anderson & Weese, 2006, 
p. 303).  Likewise, additional studies regarding the optimal times to employ strict infectious 
disease control precautions in equine settings are needed to facilitate management of this 
pathogen (Anderson & Weese, 2006).  However, while research of this nature is in progress, 
experts assert that “concurrent application of infection control practices is critical to reduce the 
likelihood of re-infection or infection of other animals or people” (Anderson & Weese, 2006, p. 
302).  Thus, it is necessary to develop and disseminate precautionary measures, infection control 
plans, and informational brochures to those who interact with horses in all settings and 
encourage handlers to seriously consider and adhere to the public health information made 
available to them.  
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Specific Project Aims 
After an extensive review of the available MRSA research, explicit project aims were 
developed based on the identified gaps in the literature.  These aims were modified after 
contacting experts in the field regarding what is specifically needed to protect the health and 
safety of those involved in the equine industry. Understanding that negative health outcomes can 
result if actions are not taken to minimize the risk of MRSA infection in humans and horses in 
equine settings, veterinarians, public health practitioners, and infectious disease specialists all 
suggested that standard precautionary measures and an infection control plan are needed for 
equine industry areas outside of veterinary practices to reduce the zoonotic transmission of 
MRSA and guide practices if an outbreak were to occur.  The experts, however, were cognizant 
of the restrictions and limitations of this specific study and thus geared their suggestions towards 
what would produce reasonable and applicable project outcomes that focused on using this 
project as a link between existing knowledge and future application.  Given this feedback, this 
project focused on and addressed the following aims: 
 Aim: Gain a deeper insight into the zoonotic and reverse zoonotic transmission of MRSA 
and raise awareness of the globalization of the equine industry, as well as the risk of 
equine MRSA transmission and infection.   
 
 Aim: Identify the stakeholders and platform needed to begin the process of providing 
reasonable guidance for equine MRSA control.  
 
 Aim: Address the development, utilization and performance of the Compendium. Identify 
and discuss the strengths and weaknesses of the Compendium.   
   
 Aim: Establish and discuss the practicality of using the Compendium as a template for 
the equine industry.  Establish and discuss the benefit of using the Compendium as a 
template for the equine industry. 
 
 Aim: Address potential Compendium modifications.  Provide broad Compendium 
modification examples that are practical and effective in reducing the risk of MRSA 
transmission and infection among horses and humans.      
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Research Methods and Procedures 
A. Overview of the Research Methods and Procedures 
This study consisted of literature searches and reviews on the zoonotic and reverse zoonotic 
transmission of MRSA in a variety of settings, as well as in-depth searches and reviews on 
equine MRSA specifically.  Pub Med, Medline and Google Scholar searches were used as main 
search engines for the literature searches and reviews.  Internet wide Google Scholar searches 
were also used to identify overall trends and current opinions and thoughts on issues specific to 
this project.  The majority of searchers were centered on the zoonotic and reverse zoonotic 
transmission of MRSA in equine settings; however, additional scholarly journal articles and 
other publications pertaining to precautionary measures and strategies intended to minimize the 
risk of zoonotic infections and model infection control plans were also identified and reviewed.   
Additionally, experts on MRSA in horses were contacted via email and telephone in order to 
better understand zoonotic transmission and what is needed to protect the health and safety of 
those involved in the equine industry, as well as gain insight into the most successful approach to 
correcting this deficit in the research.  Likewise, National Association of State Public Health 
Veterinarians (NASPHV) Veterinary Infection Control Committee (VICC) members and 
consultants to the committee were contacted through email so that the Compendium could be 
discussed. A phone interview with Compendium co-chair, Joni M. Scheftel, DVM, MPH, 
DACVPM, was conducted in order to understand the development and performance of the 
Compendium and discuss suggestions for this particular project.  The conversation with Dr. 
Scheftel also served as a way to identify which sections of the Compendium are modifiable and 
applicable to the equine industry.  To focus the study methods and procedures of this 
investigation, method objectives were crafted and built upon during the research process.  The 
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following research methods and procedural objectives were used to reach the previously outlined 
project aims: 
 Objective: Review the literature to identify relevant policies, agencies and clinical 
committees associated with the prevention of zoonotic disease transmission.     
  
 Objective: Review the literature to identify standard precautionary measures and 
strategies currently used to lessen zoonotic infections and reduce exposure to zoonotic 
pathogens in general.  
 
 Objective: Review the literature to identify the authorities responsible for development, 
implementation and adherence to precautionary measures and infection control plans for 
zoonotic diseases. 
 
 Objective: Explore the literature and review existing zoonotic disease outbreak control 
measures and protocols specific to MRSA and the equine industry.  
 
 Objective: Contact veterinarians, public health practitioners, and infectious disease 
control specialists that are versed in MRSA in equine populations via email and 
telephone.  Use the knowledge gained from these experts to better understand the 
zoonotic transmission of MRSA and focus the project on what is reasonable and 
beneficial.   
   
 Objective: Explore the literature and identify any existing MRSA guidelines for standard 
precautionary measures used for prevention.  Modify these precautionary measures for 
use by the equine industry.   
 
 Objective: Contact the National Association of State Public Health Veterinarians 
(NASPHV) Veterinary Infection Control Committee (VICC).  Specifically, contact the 
NASPHV VICC members via email and telephone that co-authored the Compendium.  
Use the knowledge gained from these contacts to understand the strengths and 
weaknesses in the Compendium and current Compendium performance outcomes.  Use 
the knowledge gained from these contacts to modify sections of the Compendium that are 
applicable to the equine industry.   
 
 
Information and knowledge gleaned from the above project research methods and procedural 
objectives were used to identify any existing precautionary measures intended to reduce the risk 
of MRSA exposure and infection in the equine industry.  In addition, literature searches and 
reviews were used to gain a deeper insight into the zoonotic transmission of MRSA and raise 
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awareness of the globalization of the equine industry, as well as the risk of equine MRSA 
transmission and infection.  Analysis of the Compendium was used to identify the strengths and 
weaknesses of the Compendium and establish the practicality of using the Compendium as a 
template for the equine industry.  Synthesis of findings guided the development of Compendium 
modifications that are practical and effective in reducing the risk of equine MRSA transmission 
and infection. 
B. Institutional Review Board Considerations 
A letter of determination for this project was sent to the Vice Provost of Research 
Compliance at Drexel University College of Medicine in Philadelphia, Pennsylvania.  Upon 
receipt of the letter of determination, the Office of Regulatory Research Compliance at Drexel 
University College of Medicine reviewed the project.  This particular project has no research 
design and is therefore not considered human subject research and is not governed by the HHS or 
FDA human protection regulations appearing at 45 CFR part 46 and 21 CRR parts 50 and 56.  
Thus, this project was granted permission to proceed without further consideration from the 
Institutional Review Board (IRB).  
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Results 
Data  
In addition to reviews of the current literature, experts on MRSA in horses were contacted 
via email and telephone in order to better understand zoonotic and reverse zoonotic transmission 
and what is needed to protect the health and safety of those involved in the equine industry (see 
Appendix A for email correspondences).  Likewise, the National Association of State Public 
Health Veterinarians (NASPHV) Veterinary Infection Control Committee (VICC) members and 
consultants to the committee were contacted through email so that the Compendium could be 
discussed (see Appendix A for email correspondences). A phone interview with Compendium 
co-chair, Joni M. Scheftel, DVM, MPH, DACVPM, was conducted on Thursday, February 18, 
2010 at 2:00pm CST in order to understand the development and performance of the 
Compendium and discuss suggestions for this particular project.  The conversation with Dr. 
Scheftel also served as a way to identify which sections of the Compendium are modifiable and 
applicable to the equine industry.   
The information provided below is an account of the phone conversation in table format with 
Dr. Joni M. Scheftel as recalled by the author of this paper (See Appendix B for a written report 
and complete account of information obtained from Dr. Scheftel).  The information presented in 
Figures 1 – 3 includes the questions posed to Dr. Joni Scheftel, broad themes obtained from the 
provided answers to the questions, mention of stakeholder involvement, and my brief assessment 
of how the Compendium relates to the equine industry.  Future actions that need to take place in 
order for the Compendium to be used as a template for the equine industry are also included.   
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Figure 1. Compendium History and Development 
Questions Themes  Stakeholders  Assessment and Relation 
to Equine Industry 
What drove the development of the 
Compendium? 
Occupationally related 
exposure investigations  
 
Preparation needed for 
protection 
 
Importance of infection 
control guidelines 
 
Veterinary staff at 
particularly high risk 
regarding zoonotic 
infections 
Veterinarians 
Public Health Officials 
 
Physicians 
 
Infectious Disease 
Specialists 
 
National Association of 
Public Health 
Veterinarians 
Veterinary Infection 
Control Committee 
(NASPHV VICC) 
members 
Persons working in 
occupations that involve 
handling animals or persons 
participating in events that 
involve frequent contact with 
animals are at risk of 
zoonotic infections. 
 
The Compendium is written 
for veterinarians in private 
practice, but certain sections 
are universal and can be 
modified for the equine 
industry.  
When and how did practitioners 
decide there was a need for a 
document covering this material? 
Need identified after the 
2003 MPXV infections 
in vets and vet techs 
 
Veterinarians are 
exposed to exotic and 
zoonotic infections 
 
Important to work 
together to create a 
document that raises 
awareness of the scope 
of zoonotic disease risk 
Veterinarians 
Public Health Officials 
 
NASPHV VICC 
members 
 
A mechanism is needed to 
guide infection control 
practices and minimize risk 
of infection and injury in the 
equine industry.   
 
 
Who are the champions of the 
Compendium? 
NASPHV VICC 
members 
 
Committee involvement 
is needed to develop and 
champion best practice 
guidelines 
 
 
NASPHV VICC 
members 
A best practice document in 
the equine industry will be 
the result of a team effort by 
specialists, public health 
officials and industry leaders. 
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Figure 2. Compendium Composition and Agency Involvement 
Questions Themes Stakeholders Assessment and Relation to 
the Equine Industry 
Who has the authority to 
modify the Compendium and 
how can changes be made to 
it?  
NASPHV VICC 
members and 
consultants to the 
committee have 
modification authority 
 
Modifications are based 
on evidence-based 
research outcomes and 
must be agreed upon by 
members 
 
Some sections of the 
Compendium contain 
universal barrier 
precautions that do not 
require much adaptation  
NASPHV VICC 
members 
 
Consultants to the 
Committee 
It is possible to modify certain 
sections of the Compendium and 
apply them to the equine industry.   
 
The Compendium has the capacity 
to be used as a template for the 
equine industry, if a committee of 
prominent equine industry leaders, 
experienced MRSA researchers, 
experts with significant 
knowledge of MRSA in horses, 
and equine farm infection control 
specialists participate in 
development and on-going 
modifications.   
Is there potential that the 
Compendium will be 
championed by the American 
Veterinary Association 
(AVMA) and identified as a 
best practice guide by the 
AVMA? 
AVMA does not 
currently endorse 
Compendium as best 
practice guide, but does 
publish it in scholarly 
journal (JAVMA) 
 
Endorsement of best 
practice guides such as 
the Compendium is 
often contingent on 
other successful 
agencies championing 
the process 
NASPHV VICC 
members 
 
Consultants to the 
Committee 
 
AVMA 
 
American Animal 
Hospital Association 
(AAHA) 
A best practice document in the 
equine industry will gain strength 
and recognition, if additional 
agencies participate in its 
development and champion its 
use. 
Is the Compendium something 
that should be used in all 
veterinary practices and 
hospitals? 
Useful in all settings, 
but modifications must 
be made to meet the 
needs of each individual 
practice and situation 
 
Depending on the 
setting, some sections of 
the Compendium are 
more useful than others  
 
As a next step, an  
adaptable model 
infection control plan 
was developed   
NASPHV VICC 
members 
 
Consultants to the 
Committee 
 
Veterinarians in private 
practice 
 
Veterinarians practicing 
in hospitals 
Professionals in the equine 
industry and experts in the field of 
MRSA in horses can collectively 
decide what in the Compendium is 
applicable to the industry and 
adapt those guidelines 
accordingly. 
 
Adaption of relevant guidelines 
can serve as starting point for the 
equine industry and link existing 
knowledge with practical 
application.  
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Should the use of the 
Compendium and any 
modifications be regulated 
state by state or through 
federal government? 
The Compendium 
should not be regulated 
by government on any 
level, since it is not 
endorsed by the AVMA  
 
Compendium written as 
a document that is to 
provide guidance, not as 
a regulatory document 
that requires strict 
enforcement 
 
Regulatory action and 
government 
involvement not a 
viable way to gain 
industry buy-in  
NASPHV VICC 
members 
 
Consultants to the 
Committee 
 
Veterinarians in private 
practice 
 
Animals Handlers and 
Caretakers 
 
Community Members 
 
 
Transmission of MRSA between 
horses and humans and risk of 
infection needs to first be tackled 
within the equine industry by 
influential industry members. 
 
Once awareness of the issue is 
raised and there is evidence of 
industry buy-in and acceptance, a 
mechanism for regulating and 
enforcing practices can be 
discussed. 
 
Depending on the outcomes of 
raising awareness, government 
involvement may not be 
necessary.  With help from a 
structured committee that 
provides basic infection control 
guidelines, members of the equine 
industry may have the capacity to 
protect themselves and others 
without regulatory action. 
 
While governmental function is 
not in regulation or enforcement, 
government does have a role in 
funding and education   
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Figure 3. Compendium Outcome Measures and Performance 
Questions Themes Stakeholders Assessment and Relation 
to the Equine Industry 
How is the Compendium 
currently being used in 
veterinary private practices? 
 
How is the Compendium 
implemented by veterinary 
professionals in private 
practice? 
 
How often are the 
Compendium guidelines and 
the infection control plan 
model used in private 
practice? 
 
Are there any examples of 
when the Compendium (or 
parts of the Compendium) was 
used? Describe the outcomes. 
Unknown 
Outcome measures are 
not in place 
 
Information on 
implementation of the 
Compendium in private 
practice and adherence 
to its guidelines are 
unavailable 
 
Surveillance reporting 
mechanism is absent 
 
Evaluations are 
unavailable 
 
An intervention is 
needed to document 
evidence and outcomes 
 
 
 
 
NASPHV VICC 
members 
 
Consultants to the 
Committee 
 
Veterinarians in private 
practice 
 
Animals Handlers and 
Caretakers 
 
Equine Community 
Members 
 
General Community 
Members 
A next step for the 
Compendium is to set up a 
surveillance reporting 
mechanism that can track, 
document and evaluate 
outcomes.  
 
A mechanism for reporting and 
surveillance will be needed in 
the equine industry in order to 
document evidence and 
evaluate the benefit of raising 
awareness and practicing 
standard infection control 
practices.  Self-reporting from 
farms is a potential option. 
 
Once data is collected and 
evaluations are made, it will be 
possible to highlight which 
precautions are most useful in 
specific settings.  These 
precautionary measures and 
standards can then be made 
available to the equine 
community and used 
accordingly.    
What sections of the 
Compendium relate most to 
public health and have 
potential for adaptation 
outside of private veterinary 
hospitals? 
Personal protective 
actions and equipment 
are modifiable 
 
Environmental infection 
control guidelines are 
modifiable 
 
Infection control plans 
are modifiable 
 
 
 
 
 
 
Veterinarians in equine 
practice 
 
Horse Handlers and 
Caretakers 
 
Equine Community 
Members 
 
Equine farm infection 
control specialists 
 
MRSA experts 
 
General Community 
Members 
Preventative measures are 
relatively universal and the 
personal protective actions, 
personal protective equipment, 
cleaning and disinfection of 
equipment, and environmental 
surfaces sections of the 
Compendium, as well as the 
written infection control plan, 
can potentially be modified for 
the equine industry and 
applicable to horse events and 
equine farm settings. 
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What are your 
recommendations for future 
infection control documents? 
Collaborative 
committee effort is 
needed to make an 
impact and provide the 
best possible practices 
and guidelines 
 
Future infection control 
documents will overlap 
with current documents 
 
Important to incorporate 
emerging evidence-
based research in new 
infection control 
documents 
 
Infection control 
documents should be 
practical and science-
based 
 
 
Veterinarians in equine 
practice 
 
Horse Handlers and 
Caretakers 
 
Equine Community 
Members 
 
Equine farm infection 
control specialists 
 
MRSA experts 
 
General Community 
Members 
A committee approach will 
help ensure buy-in and help 
recommendations gain 
credibility in the equine 
industry. 
 
Modified sections of the 
Compendium or newly 
developed infection control 
plans and precautionary 
measures specific to the equine 
industry should be practical 
and easy to understand, so that 
all equine community members 
can have access to the tools 
necessary to minimize risk and 
reduce infection. 
Do you have anything else to 
add or any other suggestions 
for me to consider as I move 
forward with my project? 
Consider specialist 
support and committee 
involvement 
 
Investigate existing 
documents and build off 
of what is already in 
circulation 
 
Network and gain 
assistance from 
colleagues  
 
Facilitate industry buy-
in by raising awareness 
and providing education 
at local level 
Veterinarians in equine 
practice 
 
Horse Handlers and 
Caretakers 
 
Equine Community 
Members 
 
Equine farm infection 
control specialists 
 
MRSA experts 
 
Prominent equine 
industry leaders 
 
General Community 
Members 
Sufficient specialist support 
and committee involvement is 
needed to move precautionary 
measures and infection control 
plans specific to the equine 
industry forward. 
 
Certain sections of the 
Compendium can be used as a 
jumping off point for the 
equine industry. 
 
Equine industry buy-in early 
on in the research process is 
crucial.  
 
Raising awareness of 
infectious disease transmission 
and infection in the equine 
industry and providing 
education are key first steps.  
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Discussion 
Justification for the Study 
According to Dr. J. Scott Weese, internationally renowned specialist on MRSA in horses, "all 
aspects of the equine industry need to be aware of this veterinary and zoonotic pathogen, because 
MRSA is likely to be an increasing concern in equine medicine" (Personal Communication, 
February 12, 2010).  MRSA infections are not only associated with illness and death in the 
human population, but have also emerged as a serious cause of disease in many animal species, 
including horses (Anderson et al., 2008; Elchos et al., 2008; Hanselman et al., 2006; Leonard & 
Marley, 2008; Oehler et al., 2009; Weese et al., 2005a; Weese et al., 2005b;  Weese & Rousseau, 
2005; Weese, 2007a).  Recent research makes it quite clear that horses comprise a potential 
source of MRSA to humans and humans are capable of transmitting the disease back to horses, 
as well as other animals and humans (Anderson et al., 2008; Baptiste et al., 2005; Farr, B.M., 
2004; Hanselman et al., 2006; Huijsdens et al., 2006; Lee, 2003; Leonard & Markey, 2008; 
Morris et al., 2006; Tomlin et al., 1999; Vitale, Gross & Weese, 2006; Weese, 2005; Weese et 
al., 2005a; Weese et al., 2005b; Weese, 2007a; Weese, 2007b; Wulf et al., 2006; Yasuda et al., 
2000).  Moreover, both humans and horses can serve as MRSA reservoirs and facilitate 
widespread MRSA colonization and infection (Anderson et al., 2008; Baptiste et al., 2005; Farr, 
B.M., 2004; Hanselman et al., 2006; Huijsdens et al., 2006; Lee, 2003; Leonard & Markey, 
2008; Morris et al., 2006; Tomlin et al., 1999; Vitale, Gross & Weese, 2006; Weese, 2005; 
Weese et al., 2005a; Weese et al., 2005b; Weese, 2007a; Weese, 2007b; Wulf et al., 2006; 
Yasuda et al., 2000).  This potential for transmission between horses and humans in both 
directions is a cause for concern and researchers stress that equine MRSA is something that must 
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not be ignored (Anderson et al., 2008; Weese, 2005; Weese et al., 2005a; Weese et al., 2005b; 
Weese & Rousseau, 2005; Weese, 2007a; Weese et al., 2008; West, 2009).  
Recent investigations have shown that the MRSA colonization rate in the general human 
population is approximately 0.2-3.5%, but that contact with horses can dramatically increase the 
risk of MRSA colonization for humans (Anderson et al., 2008; Weese, 2005; Weese et al., 
2005a; Weese et al., 2005b; Weese & Rousseau, 2005; Weese, 2007a; Weese et al., 2008; West, 
2009).  For example, some studies have shown that MRSA colonization rates are up to 10-14 
times more common in equine veterinarians as compared to the general population and that 
MRSA is, without a doubt, an occupational risk factor for large-animal veterinarians (Anderson 
et al., 2008; Weese, 2005; Weese et al., 2005a; Weese et al., 2005b; Weese & Rousseau, 2005; 
Weese, 2007a; Weese et al., 2008; West, 2009).  Equine veterinarians, however, are not the only 
group of people that come in close contact with horses on a daily basis.  People outside 
veterinary practices, such as equestrians, jockeys, horse trainers and coaches, stable managers, 
exercise riders, grooms, farriers, personal horse farm owners, horse show jumping event 
personnel, horse racing, steeplechase and polo event personnel, horse keepers, herd cowboys and 
cowgirls, western riders, mounted patrol units, and horse enthusiasts all interact with horses 
routinely.  Thus, researchers posit that people with frequent and persistent contact with numerous 
horses, not equine veterinarians alone, are at the highest risk of zoonotic transmission of MRSA 
(Anderson et al., 2008; Morley, 2004; Weese, 2005; Weese et al., 2005a; Weese et al., 2005b; 
Weese & Rousseau, 2005; Weese, 2007a; Weese et al., 2008).   
Unfortunately, data on equine MRSA infections outside the clinical setting and the overall 
annual incidence of equine MRSA is unavailable, because most colonized and/or infected horses 
and their human handlers rarely exhibit clinical signs of the disease (Morley, 2004).  This, 
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however, does not diminish the severity of MRSA, nor does it downplay the major role that 
contact between humans and horses plays in the spread and persistence of MRSA on horse 
farms, in veterinary clinics and among the community (Anderson et al., 2008; Farr, B.M., 2004; 
Leonard & Markey, 2008; Morley, 2004; Weese, 2005; Weese et al., 2005a; Weese et al., 2005b; 
Weese & Rousseau, 2005; Weese, 2007a; Weese et al., 2008).  While research is sparse, some 
studies have reported that horses in the general population have MRSA colonization rates of 0-
5%, but MRSA prevalence on some horse farms can surpass 50% (Weese & Rousseau, 2005; 
Weese, 2007a).  This provides further evidence that horses are a source of colonization and 
infection for people and those involved with horses are exposed to MRSA at greater rates as 
compared to the general public (Anderson et al., 2008; Leonard & Markey, 2008; Farr, B.M., 
2004; Weese, 2007a; West, 2009).   
Given this information, it is justifiable to conduct research and develop interventions that 
minimize the risk of MRSA infection in the equine industry.  Because of the risks posed by the 
transmission of MRSA between horses and humans, it is essential that standard precautionary 
measures for MRSA prevention are developed and a MRSA infection control management plan 
is established to help protect the health of persons involved in all sectors of the equine industry.  
The products of this project - gaining a better understanding of equine MRSA and zoonotic 
transmission, raising awareness of the scope of zoonotic disease risk in equine settings, 
addressing the development and current performance of the Compendium, establishing the 
practicality and benefit of using the Compendium as a template for the equine industry, and 
providing a sample of potential Compendium modifications that are practical and effective in 
reducing the risk of MRSA infection among horses and handlers - will connect existing 
knowledge on MRSA in horses with a zoonotic disease control template.  This connection will 
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serve a dual purpose and work as a mechanism to raise awareness and a stepping stone for future 
research.   
Assessment of the Compendium and synthesis of findings, combined with background 
research on equine MRSA and existing information from experts, will set up a situation in which 
it is possible to better understand what is needed to meet equine industry needs and to judge 
whether the Compendium is capable of meeting those needs.  In addition, it is worth mentioning 
that if adequate time and energy is committed to practicing standard precautionary measures and 
following infection control plans, MRSA and its associated symptoms can potentially be 
eradicated without the use of antibiotics (Weese, 2007a).  While future controlled studies 
investigate community equine populations in order to better understand and evaluate risk factors 
for horses and their human associates, researchers suggest that infectious disease awareness, use 
of control plans, and adherence to precautionary measures are the keys to minimizing MRSA 
risk in the equine industry (Anderson et al., 2008; Weese, 2007a; West, 2009). 
Figure Analysis and Conclusion Preface 
The information provided below is an analysis of Figures 1 – 3.  As part of the discussion, 
these analyses are meant to synthesize the information in each figure and to determine how the 
Compendium relates to the equine industry.  Also included in these analyses is a discussion of 
the strengths and weaknesses of moving the Compendium forward as a template in the equine 
industry, as well as mention of the processes needed to create awareness and develop guidelines 
regarding equine MRSA.  Following the analyses of Figures 1 – 3 are broad examples of 
potential Compendium modifications that can create an immediate and positive impact on the 
equine industry.  To conclude this project, policy implications and recommendations stemming 
from this research are reviewed and future avenues of study are provided.        
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Analysis of Figure 1. Compendium History and Development 
 Based on the history and development of the Compendium and a review of the existing 
literature, it is clear that occupationally related exposure investigations are needed to spearhead 
any type of best practice or infection control guiding document.  Given that preparation is needed 
for protection in regards to zoonotic infections, surveillance, data collection, and evidence-based 
research must precede any protection guidelines intending to minimize risk.  Without data 
collection and evaluation, it is not possible to establish need and identify which precautions are 
most useful in specific settings and under certain conditions.   
However, scholarly research has broadly proven that persons working in occupations that 
involve handling animals or persons participating in events that involve frequent contact with 
animals are at risk of zoonotic infections.  Research has also proven that many barrier 
precautions are, in fact, universal and can reduce exposures and disease risk in several settings.  
Thus, it follows that while a specific mechanism is needed to guide infection control practices 
and minimize risk of infection and injury in the equine industry, existing guidelines (such as the 
universal precautions in the Compendium) are useful in industries outside of private veterinary 
practices, if modified correctly.  These universal precautions and modifiable guidelines are 
strengths associated with moving the Compendium forward as a template for the equine industry.      
Modification of existing guidelines and/or development of a specific best practice document 
that is targeted towards MRSA prevention in general equine personnel, however, is complicated 
and will require the involvement of a committee of people comprised of prominent equine 
industry leaders, experienced MRSA researchers, experts with significant knowledge of MRSA 
in horses, and equine farm infection control specialists.  On the surface, this may seem as a 
weakness of the Compendium in regards to its use as a template for the equine industry.  
68 
 
Conversely, the importance of committee involvement and collaboration is actually a strength of 
moving the Compendium forward in the equine industry in that it demonstrates the detailed 
process that is needed to create equine MRSA awareness and develop guidelines.   
Committee involvement is needed to not only modify guidelines and create a document that 
raises awareness of the scope of zoonotic disease risk, but also to champion its development and 
use among various stakeholders (equine veterinarians, public health officials, infectious disease 
specialists, NASPHV VICC members, industry agencies, animal handlers, MRSA experts) and 
industry members.  Therefore, a best practice document in the equine industry will be the result 
of a team effort by specialists, public health officials, and industry leaders actively working 
together.                                   
Analysis of Figure 2. Compendium Composition and Agency Involvement 
 The composition of the Compendium further highlights the importance of committee and 
agency involvement when creating, modifying and endorsing best practice guides.  Currently, 
NASPHV VICC members and consultants to the committee have Compendium modification 
authority.  Every two years, the committee reconvenes and makes any necessary changes based 
on recent evidence-based research outcomes and clinical experiences.  While the modifications 
made to the Compendium specifically are centered on precautions for veterinarians in private 
practices, it is noted that certain sections of the Compendium contain universal precautions that 
are rarely altered and are thus suitable for use in other industries.   
Parts of the Compendium are applicable to the equine industry and these divisions, which are 
discussed in the Compendium Modifications section below, are additional strengths associated 
with moving an equine version of the Compendium forward.  A combined key finding from 
Figure 1 and Figure 2 is that the Compendium has the capacity to be used as a template for the 
69 
 
equine industry, if a committee of prominent equine industry leaders, experienced MRSA 
researchers, experts with significant knowledge of MRSA in horses, and equine farm infection 
control specialists participate in development and on-going modifications.  
 In addition, based on the Compendium composition and external literature reviews, it is 
evident that committee participation and agency involvement is needed not only for the 
development and modification of a best practice guide, but also for endorsement and industry 
buy-in.  Endorsement of a best practice guide such as the Compendium is often contingent on 
other related and successful agencies within the field championing the process.  For example, the 
Compendium gained strength as a best practice document for private veterinary practices, in part, 
because of powerful and successful agencies such as the American Veterinary Medical 
Association (AVMA) and the American Animal Hospital Association (AAHA) becoming 
involved in its development and supporting its initiatives.   
Given this information, it follows that a best practice document in the equine industry will 
gain strength, support and recognition in the horse world, if overarching regulatory agencies 
already firmly in place in the industry such as the United States Equestrian Federation (USEF) 
and the United States Hunter Jumper Association (USHJA) participate in its development, 
dissemination and implementation.  Furthermore, if the USEF and USHJA champion an equine 
version of the Compendium, it is more likely that those involved in the industry will seriously 
consider the scope of equine zoonotic disease risk and adhere to any provided guidelines without 
strict enforcement. 
 Once committee and agency involvement are secured, adaptation of relevant guidelines from 
the Compendium can serve as a starting point for the equine industry.  This starting point can link 
existing knowledge with practical application, making it possible for professionals in the equine 
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industry and experts in the field of MRSA in horses to collectively decide what in the 
Compendium is applicable to the industry and adapt those guidelines accordingly in the short-
term.  Time and resources will be needed to develop a complete working document for the 
equine industry in the long-term and thus focusing on raising awareness and adapting existing 
guidelines at this time is most appropriate, so that a positive and immediate health impact can be 
made on the equine industry and associated communities without further delay. 
 The above analysis of the composition of the Compendium highlighted the importance of 
committee and agency involvement during the creation, modification and endorsement of best 
practice guides.  Also of importance, however, is the role of government and regulatory action in 
regards to avenues of implementation and enforcement of a best practice document and/or 
infection control guidelines.  According to Dr. Scheftel, the Compendium is not and should not 
be regulated by government on any level, because it is purely written as a document that 
provides guidance for infection control.  The Compendium aims to minimize risk of interspecies 
and zoonotic transmission of disease, minimize risk of occupational zoonotic infections and 
minimize the risk of infection from new, emerging infectious diseases.  In the case of the 
Compendium, regulatory action and government involvement was not a viable way to gain 
industry buy-in, mainly because governmental involvement would be seen as intrusive and 
unnecessary among veterinarians in private practice.  Moreover, governmental regulation and 
enforcement of guidelines in private veterinary practices across the nation would not only be 
unwelcome, but would be unrealistic given the current economic and political climate.  Also, 
governmental involvement and regulatory action in this scenario would affect veterinarian’s 
professional liability (J. Scheftel, Personal Communication, February 18, 2010).     
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During the development of the Compendium, the widespread understanding among the 
NASPHV VICC was that in order to protect themselves and others, they needed to first provide a 
document that offered guidance to their colleagues and industry members and then encourage the 
adoption of new practices and behavior change over time.  This line of reasoning is a practical 
way of approaching the equine industry as well.  Overarching governmental involvement in 
private industries is often resisted and thus the transmission of MRSA between horses and 
humans and the risk of infection on personal horses farms and at horse shows needs to first be 
tackled within the equine industry by influential industry members.  Presently, offering education 
and guidance through a committee-championed, flexible document or set of guidelines will 
provide consistency and a much needed foundation for the equine industry without causing 
conflict or negative reactions.  Moreover, given that the topic of equine MRSA is an evolving 
science and currently manifesting itself in unique and new situations, now is not the appropriate 
time to consider or implement regulatory action.  Once awareness of the issue is raised and there 
is evidence of industry buy-in and acceptance, a mechanism for regulating and enforcing 
practices can be discussed later, if needed.   
It is important to note, however, that governmental entities are not without a prominent role 
in equine MRSA prevention.  Presently, the governmental role in equine MRSA and zoonotic 
disease prevention is not in regulation and enforcement of guidelines, but in funding further 
research, financing education, and supporting public health initiatives.  With financial support in 
the form of grant monies from governmental entities, public health agencies and researchers will 
not only be able to continue research, but will also be able to partner with local equine industry 
members and start the process of providing educational guidance regarding equine MRSA and 
zoonotic disease prevention.  Thus, while not in its traditional regulatory and enforcement role, 
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governmental support and involvement is essential in order to successfully move equine MRSA 
prevention awareness and education forward. 
Analysis of Figure 3. Compendium Outcome Measures and Performance 
 In order to define and measure progress of an organization, program or intervention, 
assessment and outcomes measures, as well as other performance indicators, are critical.  
Outcome measures and performance indicators, however, are not in place for the Compendium.  
Information on the implementation of the Compendium in private practice and adherence to its 
guidelines is unavailable.  Furthermore, surveillance reporting mechanisms and performance 
evaluations are absent.  There is no process in place to document how or if the Compendium is 
being used and no way of evaluating the benefit (or lack thereof) of its guiding principles.  This 
is problematic for the Compendium in its own right and when considering its use for the equine 
industry.  However, while lack of outcome measures and performance indicators is a major 
deficiency of the Compendium, making note of and correcting this assessment gap now will 
benefit the equine industry in the future.  This current Compendium deficiency makes it evident 
that an intervention will be needed to document evidence and assess the outcomes of equine-
specific guiding principles.  Outcomes measures and performance indicators expose areas that 
are in need of improvement and adjustment, but also reveal areas that are highly beneficial.   
 A next step for the Compendium specifically is to set up a surveillance reporting mechanism 
that can track, document and evaluate outcomes.  A mechanism for reporting and surveillance 
will also be needed in the equine industry in order to document evidence and evaluate the benefit 
of raising awareness and practicing standard infection control practices.  If organized and 
promoted, a potential surveillance mechanism option at this time for the equine industry is self-
reporting on farms and on horse show grounds.  If self-reporting on farms is implemented, data is 
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collected and evaluations are made, it will be possible to highlight disease risk and identify 
which precautions are most useful in reducing risk under specific settings and conditions.  These 
precautionary measures and standards can then be made available to the equine community and 
applied accordingly.   
 Despite the Compendium’s limitations and deficiencies, it is extremely important to note that 
the Compendium’s guiding principles should not be disregarded when considering moving it 
forward as a template in the equine industry or developing an entirely new equine-specific 
guiding document.  The Compendium has much to offer the equine industry in regards to 
development and process.  For example, the history, development and composition of the 
Compendium has made it clear that future equine-specific infection control guidelines must be 
the result of a collaborative committee effort involving specialist support, if stakeholders intend 
to make an impact and provide the best possible practices to industry members and the 
community.  This committee approach, in turn, will also help to ensure industry buy-in and help 
recommendations gain credibility in the equine industry.  In addition, analyzing the Compendium 
has made it evident that future infection control documents will overlap with current documents 
and any on-going modifications should incorporate cutting-edge evidence-based research. 
Discussion of Compendium Modifications 
As briefly discussed earlier, the Compendium is not a perfect template for the equine 
industry, but many aspects of this infectious disease control guiding document are feasible for 
industries outside private veterinary practices.  Preventative measures are relatively universal and 
the personal protective actions, personal protective equipment, cleaning and disinfection of 
equipment, and environmental surfaces sections of the Compendium, as well as the written 
model infection control plan, are modifiable for the equine industry and applicable to horse show 
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events and equine farm settings.  It is noteworthy to mention that modified sections of the 
Compendium or newly developed infection control plans and precautionary measures specific to 
the equine industry should be practical and easy to understand, so that all equine community 
members have access to the tools necessary to minimize risk and reduce infection and are able to 
employ them without difficulty.  Such broad examples of application to the equine industry 
include, but are not limited to, the following precautions listed below. 
 Wash Hands Frequently with Soap and Water Vigorously for 20 Seconds 
 Wash Hands Between Handling Different Horses 
 Wash Hands Before Eating and Drinking 
 Disinfect Tack Daily 
 Disinfect Grooming Tools Daily 
 Wash Soiled Laundry (e.g. Saddle Pads, Girth Covers, Sheets, Blankets, Fleece-Lined 
Boots) Daily with Standard Laundry Detergent and Machine Dry 
  Use Different Equipment and Tools on Each Horse 
 Limit Contact of Different Groups of Horses 
 Use Gloves when Handling a Horse with an Open Wound 
 Disinfect and Cover Open Wounds on Horses  
 Disinfect and Cover Open Wounds on Humans Handling Horses 
 Quarantine Horses with Infection 
 Have a Written Infection Control Plan On Site that Reflects Infection Control Principles 
and Provides Contact Information, Resources and References 
 Create and Enforce Employee Vaccination Policies and Record Keeping Strategies 
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 Notify Immunocompromised Individuals of their Higher Risk of Exposure to Zoonotic 
Pathogens  
 Document and Report Any Infection with Zoonotic Agents to the Public Health Authority  
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Policy Implications and Recommendations 
Policy Implications 
Remembering that the overarching expectation for this project is that it serves as an initiative 
to spur interest in this area, it naturally follows that associated policy implications of this 
research revolve around raising awareness and moving the topic of zoonotic transmission of 
equine MRSA forward.  As briefly mentioned earlier, the governmental role in equine MRSA 
and zoonotic disease prevention at this time is not in regulation and enforcement of guidelines, 
but in funding further research, financing education, and supporting public health initiatives that 
target this issue.  Thus, it follows that initial and successful entry into the equine industry and 
promotion of infection control measures are contingent on public health officials receiving 
funding from governmental sources in order to raise awareness, provide education and work 
directly with industry members.  With financial support in the form of grant monies from the 
government, county level public health agencies can partner with local horsemen to gain access 
to the industry and to begin the process of providing educational guidance regarding equine 
MRSA and zoonotic disease prevention.   
After funds are secured, the most reasonable and practical approach available to public health 
officials for entering the industry and facilitating forward movement at this time is the utilization 
of a “guidance perspective” in which education is the key component.  Approaching the industry 
with educational guidance and forming a grassroots partnership with local horsemen is a viable 
way of entering the equine industry at a county level and implementing change from the bottom 
up.  If local industry members, with educational guidance from public health officials, take 
action and start the process of change in one area, it is likely that others will adopt similar 
behaviors and a spillover effect will take place throughout the industry.  This guidance 
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perspective and grassroots partnership will provide consistency and a much needed starting point 
for the equine industry in regards to safety and health promotion without causing conflict or 
negative reactions from the equine community.  Moreover, a committee comprised of actively 
concerned industry members and public health officials that champion direct, yet flexible, 
precautionary measures and infection control principles will likely form out of this grassroots 
initiative.  
In order to follow through with the guidance perspective and encourage change through 
voluntary action in this situation beyond the county level, it is necessary to forge a partnership 
among local equine industry members, prominent equine industry leaders, influential members 
of the USEF and USHJA, experienced MRSA researchers, experts with significant knowledge of 
MRSA in horses, equine farm infection control specialists, equine veterinarians and public health 
practitioners.  These partners need to come together as a committee and collectively agree to 
make progress from a public health perspective that is suitable for the equine industry.  The 
committee can use certain sections of the Compendium as a template to generate basic guidelines 
for the equine industry and raise awareness through a social marketing campaign.  A heavy 
emphasis on self-reporting on farms and use of universal precautions should be included as part 
of the social marketing campaign.  To proliferate guidelines and control mechanisms into the 
equine industry, the creation and dissemination of an equine MRSA informational brochure is an 
option.   
The platform for moving all of this forward from a public health and policy standpoint is to 
approach the equine industry with a voluntary guidance perspective that encourages 
collaboration.  Starting the process of change with a “softer” hand and including the industry in 
decision-making is a way to raise awareness, make progress, and facilitate partnership programs 
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that actively work together to reduce harm and promote healthy practices.  With help from the 
industry, the USEF/USHJA, and a structured specialist committee that provides basic infection 
control guidelines, it is likely that the equine industry as a whole will have the capacity to 
adequately protect themselves and others without further action; which, in turn, will reduce the 
burden of MRSA infection and disease in horses and their handlers and improve overall public 
health in the community.   
Recommendations 
In order to move MRSA infection control forward in the equine industry, it is recommended 
that county level public health researchers and agencies, with the aid of governmental funding, 
form a voluntary partnership program with local equine industry members and focus on the 
following key concepts listed below. 
 Awareness and Education 
 Committee Involvement 
 Agency Participation 
 Industry Buy-In 
 Specialist Support 
 Collaboration and Partnership 
 Compendium Modifications 
 Guiding Infection Control Principles 
 Equine MRSA Brochure Development and Dissemination 
 Self-Reporting on Farms and Horse Show Grounds 
The research is unclear regarding specific infection control practices needed at the farm level 
and on active horse show grounds to lessen the transmission of and resultant infections by equine 
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MRSA and other zoonotic agents at this time.  Moreover, precise infection control practices are 
variable and often dependent on the situation.  However, broad infection control practices that 
are effective in reducing zoonotic disease transmission and infection are available.  Such broad 
guidelines include isolating infected or colonized horses, use of protective barriers (gloves) when 
handling infected horses, proper hand hygiene among horse handlers, limiting contact of 
different groups of horses and thoroughly disinfecting tack and grooming tools (Weese, 2007a).  
Making these broad guidelines available to the equine industry is feasible, if the partners 
collaborate and keep all the above key concepts in mind during the process.  In addition, it is 
further recommended that public health researchers and agencies and local equine industry 
members together partner specifically with USEF and USHJA leaders in order to gain strength 
and recognition and offer available guidance to the equine industry as a whole without further 
delay.    
As a key first step, this voluntary partnership program between public health agencies and 
the USEF and USHJA can focus on raising awareness of infectious disease transmission via a 
social marketing campaign.  Raising awareness will uncover the scope of zoonotic disease 
transmission and infection and facilitate industry buy-in, which is crucial early on in the research 
and development process.  Furthermore, the partners can network and gain the specialist support 
and committee involvement they need to move precautionary measures and infection control 
plans specific to the equine industry forward.   
In the short-term, the partners can collectively decide which sections of the Compendium are 
modifiable and useful to the equine industry and work on creating and disseminating an equine 
MRSA brochure that outlines the pertinent information regarding transmission control.  The 
intention of this brochure is to provide those in the equine industry with a readable and easily 
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accessible document that summarizes broad infection control principles such as hand hygiene 
and use of protective barriers and encourages self-reporting on farms.  In order to make this 
information available to a wide range of people, the partners can request that the brochures are 
placed in horse show secretary offices across the nation and that equine MRSA information and 
infection control guidelines are printed in highly circulating horse magazines such as The 
Chronicle of the Horse.   A comprehensive equine-specific infection control document can be 
developed over the long-term when time and resources are available.             
Lastly, when considering available avenues of equine MRSA control, it is important to 
remember that horses are companion animals, not livestock.  Horses within all facets of the 
equine world are not only pets and investment prospects, but a way of life for those involved 
with them.  Understanding and accepting this mentality is crucial, if public health entities are 
going to partner with the equine industry and the USEF/USHJA and collaboratively work 
together to reduce harm from zoonotic disease transmission and infection.            
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Conclusion 
Analyzing the Compendium has made it clear that creating a comprehensive infection control 
document specific to the equine industry will be a complicated process, but not an unattainable 
goal.  A guidance perspective and governmental funding and support, as well as strong 
partnerships at the local level and between public health researchers and influential leaders in the 
USEF and USHJA, are the keys to zoonotic disease prevention in the equine industry.  With 
funding and support, these voluntary partnership programs can make progress from a public 
health perspective and actively participate in the development of a comprehensive protocol that 
successfully minimizes the risk of MRSA transmission between horses and humans in equine 
settings over the long-term, while providing education and championing the use of currently 
available broad infection control guidelines that reduce harm in the short-term.   
The development and dissemination of new (or modification of existing) control mechanisms 
targeted toward the equine industry specifically will improve health and hygiene not only among 
horses and their handlers, but in the community as well.  By proliferating guidelines and control 
mechanisms into the equine industry, persons involved in handling horses, competing at horse 
events and residing or interacting on equine farms will be better protected and we will see an 
increase in the practice of precautionary measures and use of infection control plans; which, in 
turn, will reduce the burden of MRSA infection and disease in horses and their handlers and 
improve overall public health in the community.   
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Future Directions 
The overarching expectation for this project was that it serve as an initiative to not only spur 
interest in this considerable public health concern, but also to identify the method, stakeholders 
and platform needed to begin the process of providing reasonable guidance for minimizing 
equine MRSA colonization, infection and disease among people in equine settings.  This project 
has uncovered the many facets (awareness, education, governmental funding and support, 
committee involvement, agency participation, industry buy-in, specialist involvement, 
collaboration and voluntary partnership, guidance perspective) that are involved in moving 
zoonotic disease prevention forward in the equine industry.  However, additional time, energy 
and resources are needed to further advance these findings and recommendations.   
Thus, future activities stemming from this project include linking county public health 
researchers and agencies with local horsemen, linking public health researchers and agencies 
with the USEF and USHJA, attaining specialist support and committee involvement, developing 
and disseminating an equine MRSA brochure, creating a model infection control plan that is 
specific to personal horse farms and horse show grounds and implementing an infectious disease 
control protocol for the equine industry.  Additional future research related to this project 
includes recognizing effective methods of increasing awareness of zoonotic disease potential, 
identifying ways of improving broad-based infection control practices, and conducting controlled 
studies that evaluate risk factors in community equine populations. 
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APPENDIX A 
Compendium Author and MRSA Expert Email Correspondences 
CBMP Research Data Collection: Zoonotic transmission of Methicillin-resistant 
Staphylococcus aureus (MRSA): Prevention, Intervention and Policy Implications for the Equine 
Industry 
What: Email correspondences with members of the National Association of State Public Health 
Veterinarians (NASPHV) Veterinary Infection Control Committee (VICC) and consultants to the 
committee - All contacts were involved in the development and writing of the Compendium of 
Veterinary Standard Precautions for Zoonotic Disease Prevention in Veterinary Personnel 
Date: Thursday, February 12, 2010 (Additional contact and conversations continued after 
February 12, 2010 – See Below 
Who: See Below  
Joni M. Scheftel, DVM, MPH, DACVPM, (Co-Chair), State Public Health Veterinarian, 
Minnesota Department of Health, Saint Paul, MN 55155 (Co-Author of the Compendium of 
Veterinary Standard Precautions for Zoonotic Disease Prevention in Veterinary Personnel)  
Sharon G. Hopkins, DVM, MPH, Public Health Veterinarian, Public Health – Seattle & King 
County, Seattle, WA 98104 
Jay. F. Levine, DVM, MPH, DACVPM, Department of Epidemiology and Public Health, 
College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606 
Glenda D. Dvorak, DVM, MPH, Center for Food Security and Public Health, Ames, IA 5001 
Oreta M. Samples, CVT, MPH, National Association of Veterinary Technicians in America 
(NAVTA), Alexandria, VA 22304 
Jamie L. Snow, DVM, MPH, United States Department of Agriculture, Animal and Plant Health 
Inspection Service, Veterinary Services (USDA APHIS VS), Fort Collins, CO 80526 
Scott Weese, DVM, DVSc, DipACVIM (MRSA in horses expert) 
Topic of Discussion: Q and A regarding the Compendium of Veterinary Standard Precautions 
for Zoonotic Disease Prevention in Veterinary Personnel (Authored by the National Association 
of State Public Health Veterinarians (NASPHV) Veterinary Infection Control Committee 
(VICC) in 2008) 
My email to the Compendium Authors on Friday, February 12, 2010:  
My name is Ashley Martin, and I am a second year student at Drexel University School of 
Public Health in Philadelphia, PA.  For my master's thesis, I am exploring the zoonotic 
transmission of MRSA and specifically looking at prevention, intervention and policy 
implications for zoonotic infection in the equine industry.  I am looking for your guidance and 
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any suggestions you may have on my research.  Any insight that you may have on my project 
direction and answers to questions that you can provide me will be very much appreciated. The 
overarching purpose of this project is to provide reasonable guidance for minimizing MRSA 
colonization, infection and disease among people in equine settings.  Goals of this project 
include gaining a deeper insight into the zoonotic transmission of MRSA and formulating 
guidelines and precautionary measures that help control MRSA in equine settings in order to 
minimize the impact of transmission and infection.  The public health impact of this project is to 
establish procedures that reduce zoonotic transmission of MRSA and control potential MRSA 
outbreaks in the equine industry. It is predicted that the development of precautionary measures 
and formulation of an infection control plan specific to the equine industry will improve overall 
health in the human and equine population and reduce risk of infection by raising awareness in 
the industry and enhancing ability to practice appropriate safety measures.   
My expectation is that when this project is completed it will outline standard precautionary 
measures needed to reduce the risk of MRSA infection and minimize exposure to MRSA 
pathogens in the equine industry, provide a written MRSA infection control plan, and influence 
MRSA containment policies.  Based on the need for infection control guidelines specific to the 
equine industry, the products of this project will include raising awareness of the scope of 
zoonotic disease risk in equine settings, outlining outbreak control concepts, establishing 
practical and functional precautionary measures for MRSA infection prevention, developing a 
MRSA informational brochure specific to the equine industry and providing a MRSA infection 
control plan that is effective in the equine settings outside of large animal veterinary clinics. 
With all that being said, I've been encouraged by my adviser to find a working document as a 
model that I can use to help facilitate my own project.  During my research, I came across the 
Compendium of Veterinary Standard Precautions for Zoonotic Disease Prevention in Veterinary 
Personnel.  I am attempting to use this document as a guide for my own project and decided I 
would gain the most information if I contacted the authors (especially those authors that hold 
their MPH)!  I would like to take certain sections of the compendium and adapt it for the horse 
show jumping industry and other equine industries outside of veterinary hospitals.  If you are 
able to spare the time, I have a few questions about the compendium and how it is used. 
Questions: 
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1. What drove the development of the compendium?   
 
2. When and how did practitioners decide there was a need for a document covering this 
material? 
 
3. Who is the champion for the compendium?   
 
4. How can changes be made to it?   
 
5. Who has the authority to modify it?   
 
6. How is the information updated?   
 
7. Is there potential that the compendium will be championed by the AVMA and identified 
as a best practice guide? 
 
8. Do you think the compendium should be something that is used in all veterinary 
hospitals?   
 
9. Should its use (and any modifications) be regulated state by state or through federal 
government? 
 
10. How is the compendium currently being used?   
 
11. How is it implemented by practitioners?   
 
12. How often is it used?   
 
13. Do have any examples of when the compendium was used and can you describe the 
outcomes? 
 
14. What sections of the compendium do you think relate most to public health and have 
potential for adaptation outside of veterinary hospitals? 
 
15. What are your recommendations for future infection control documents?  What should 
these documents include?  
 
16. Do you have anything else to add or any other suggestions for me to consider as I move 
forward with my project? 
 
Jay F. Levine, DVM, MPH, DACVPM Response – Friday, February 12, 2010: 
Hi Ashley,  
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Thank you for sharing the details of your proposed project with me. I could answer several of 
your questions about the Compendium and Infection Control Practice in veterinary clinics. 
However, there may be some colleagues that are more actively involved in MRSA health related 
issues. I would suggest contacting Scott Weese at Guelph University about MRSA, and also 
contacting Dr. Bridig Echlos or Dr. Joni Scheftel, as they co-coordinated the development of the 
Compendium. I've copied your note to them as a form of introduction. Send me a note after you 
contact them and let me know if I can provide additional help.  
JFL 
Scott Weese, DVM, DVSc, DipACVIM Response (Dr. Weese contacted me directly after 
receiving Dr. Levine’s forwarded email)  - Friday, February12, 2010: 
Ashley, 
Jay Levine forwarded your email and I'll comment from the equine MRSA aspect. One thing that 
you need to consider is the nature of the equine industry. Guidelines that are written from 
someone outside a specialized area like this are unlikely to be accepted, I suspect. I don't know 
your background or that of your colleagues but without significant knowledge and exposure in 
the equine industry, and buy in from relevant industry groups, you may be putting a lot of effort 
into something that may not go far. A successful approach probably needs prominent 
involvement of people with good experience with MRSA in horses and infection control on 
equine farms.  There is some guidance for the equine industry in various places. We have 
information sheets for horses and pets in the Resources sections of 
http://www.wormsandgermsblog.com and http://www.equidblog.com  The Bella Moss 
Foundation has information directed at the public, with more equine-specific information coming 
out soon as part of a 2009 meeting. A 2004 Infection Control edition of Veterinary Clinics of 
North America also has some guidance, albeit a little dated now. I'm not trying to discourage you 
but it's something that I think needs to be carefully considered so that it has the best chance of 
having an impact. This is a good idea for an initiative but it probably goes beyond an MSc thesis 
considering the need for involvement of different people and groups, and ample discussion. 
Let me know if you have any questions or comments. 
Scott 
Joni M. Scheftel, DVM, MPH, DACVPM Response – Friday, February 12, 2010 
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Ashley, 
I'd be glad to speak with you about the Compendium next week. I apologize that I don't have 
time right now to write answers to all your questions! Next week, I am free on Tuesday 
afternoon, Wednesday most of the day and on Thursday afternoon. Please pick a time and we can 
make an appointment to talk about your project. 
Have a nice weekend! 
Sincerely, 
JMS 
My response to Dr. Joni M. Scheftel – Saturday, February 13, 2010 
Hi Dr. Scheftel,  
Thank you so much for taking the time to speak with me!  No need to apologize -- I'm sure you 
have a hectic schedule.  I'm grateful that everyone that I've contact about the Compendium has 
been so receptive to my email.  Next Thursday afternoon (2/18) works best for me.  I can make 
myself available whenever is most convenient for you -- just let me know. 
Best Regards, 
Ashley 
Joni M. Scheftel, DVM, MPH, DACVPM Response – Friday, February 15, 2010 
Ashley, 
Please call me at 2 PM CST at 651-201-5107. If I am not at my desk, please leave a message and 
I will call you right back! 
Sincerely, 
JMS 
Note: I confirmed the meeting with Dr. Scheftel and we are scheduled to discuss the 
Compendium on Thursday, February 18, 2010 at 2:00pm CST.  Notes from the discussion with 
Dr. Scheftel will be outlined in a separate document. 
Glenda D. Dvorak, DVM, MPH, Center for Food Security and Public Health Response – 
Tuesday, February 23, 2010 
 Hi Ashley, 
Sorry for the delay in response to your email.  I will try to answer your questions the best I can.  
What drove the development of the compendium?  When and how did practitioners decide there 
was a need for a document covering this material? 
98 
 
Much of the history or need for the compendium are addressed in the Introduction section. A 
number of factors contributed….increasing number of zoonotic disease outbreaks (especially the 
US monkeypox outbreak) highlighted the daily risk to veterinarians and their staff. While this 
was really not a “new” problem…there were no published standardized guidelines for prevention 
and protection for veterinary staff. The first meeting of the Compendium Committee was in 
2005. 
Who is the champion for the compendium?  How can changes be made to it?  Who has the 
authority to modify it?  How is the information updated?   
The champions of the compendium are Dr. Joni Scheftel and Dr. Brigid Elchos. Both are very 
passionate about this topic, saw the need, gathered the compendium committee and work 
tirelessly on writing, editing, and getting the compendium published and promoted. The 
Compendium Committee meets annually to go over the document, make any necessary 
additions, modifications, adjustments, based on current events or recent research. We meet for 
several days and literally go through the document line by line and discuss and agree upon any 
needed changes. Drs. Scheftel and Elchos then compile all the information and finalize the 
document.  
Is there potential that the compendium will be championed by the AVMA and identified as a best 
practice guide? 
Currently the Compendium is published in the Journal of the American Veterinary Medical 
Association.  JAVMA 2008; 233(3):415-432.  
Do you think the compendium should be something that is used in all veterinary hospitals?  
Should its use (and any modifications) be regulated state by state or through federal 
government? 
We (the Compendium committee) hope that veterinary clinics will adapt many of these 
guidelines for prevention. Veterinary clinics are quite diverse so I think implementing any type 
of regulation would be difficult. I don’t think that is done in human healthcare either for the same 
reason.  
How is the compendium currently being used?  How is it implemented by practitioners?  How 
often is it used?  Do have any examples of when the compendium was used and can you describe 
the outcomes? 
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The Compendium is currently published in JAVMA, which is one of the primary veterinary 
journals, so would be easily and well accessed by veterinarians. It is also available through the 
National Association of State Public Health Veterinarians website. Dr. Scheftel and Dr. Elchos 
also deliver presentations on the Compendium and the recommended preventative measures. 
Additionally, Committee members often include discussion of the Compendium when asked to 
speak. We are all quite passionate about the topic.   
 
What sections of the compendium do you think relate most to public health and have potential for 
adaptation outside of veterinary hospitals? 
 
The whole document is related to public health, but primarily targets the health and safety of 
veterinary personnel at risk of zoonotic disease exposure….however many of the preventative 
measures suggested can be used outside of the veterinary clinic….as in human health, prevention 
measures are relatively universal….it is applying them as needed and when needed! So, hand 
washing, PPE, cleaning and disinfection measures….many of these can also be applicable for 
farm settings, home settings, etc.  
 
What are your recommendations for future infection control documents?  What should they 
entail?   
As mentioned above, most preventative measures are pretty standard, however as new diseases 
emerge guidance on prevention will need to be revisited to ensure the safety of the public, 
veterinary health providers, and the animal themselves.  
 If you would like more input on the Compendium, you can contact Dr. Joni Scheftel and Dr. 
Brigid Elchos.  
Joni Scheftel, DVM, MPH, DACVPM 
E-mail: joni.scheftel@health.state.mn.us 
Brigid L. Elchos, DVM  
E-mail: Brigid@mdac.state.ms.us 
As for your project, I would suggest contacting Dr. Jeff Bender or Dr. Scott Weese for insight 
into MRSA and equine exposure. They are both well versed in MRSA and MRSA prevention. 
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They may have some suggestions for your research and they would be excellent resources of 
information on the topic. 
 Their contact information is: 
Dr. Jeff Bender, DVM, MS, DACVPM 
http://www.vdl.umn.edu/aboutVDL/staff/bender/home.html 
Dr. Scott Weese, DVM, DVSc Guelph; Dipl ACVIM 
http://www.ovc.uoguelph.ca/path/faculty/jsweese.cfm  
I hope this information helps. If you have any additional questions, please feel free to contact 
me. I am glad to help where I can. 
---Glenda  
My response to Dr. Glenda Dvorak – Tuesday, February 23, 2010 
Hi Dr. Dvorak, 
Many, many thanks for your response -- very helpful and much appreciated!  I've actually been 
in contact with Dr. Scheftel and Dr. Weese and had some very valuable phone conversations and 
am all set! 
Best Regards, 
Ashley 
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APPENDIX B 
Phone Interview with Compendium author Joni M. Scheftel, DVM, MPH, DACVPM 
Date: Thursday, February 18, 2010 
What: Phone Meeting with Dr. Joni M. Scheftel, DVM, MPH, DACVPM, (Co-Chair), State 
Public Health Veterinarian, Minnesota Department of Health, Saint Paul, MN 55155 (Co-Author 
of the Compendium of Veterinary Standard Precautions for Zoonotic Disease Prevention in 
Veterinary Personnel)  
Time: 2:00pm CST 
Topic of Discussion: Q and A regarding the Compendium of Veterinary Standard Precautions 
for Zoonotic Disease Prevention in Veterinary Personnel (Authored by the National Association 
of State Public Health Veterinarians (NASPHV) Veterinary Infection Control Committee 
(VICC)) and discussion on her professional insights and suggestions for my project 
Questions and Answers  
1. What drove the development of the Compendium?   
 
The development of the compendium was driven by the 2003 outbreak of prairie dog-
associated Monkey pox virus (MPXV) infections. During May 2003 –June 2003, an 
outbreak of monkey pox virus (MPXV) infections, initially detected in Wisconsin, 
occurred in the Midwestern United States.  African rodents imported from Ghana were 
implicated in virus introduction in the United States.  The African rodents had been 
transported and housed with native prairie dogs that were subsequently distributed as 
household pets in Wisconsin.  Veterinary and pet store staff were at risk for potentially 
serious occupationally related infections.  MPXV infections and prairie dog exposures in 
veterinary facilities and pet stores really highlighted the need for occupationally related 
exposure investigations.  Moreover, it was an eye-opener for veterinarians and veterinary 
technicians that they need to prepare and do more to protect themselves.  It was this 
outbreak that emphasized the importance of standard infection control guidelines that are 
developed for veterinary settings and also encouraged the use of standard precautions 
such as personal protective equipment.  Studies that occurred after the 2003 Wisconsin 
MPXV outbreak identified protective and risk factors for occupationally transmitted 
infections and worked to determine veterinary work practices agreeable to infection-
control guidelines.  Discussion surrounding this outbreak revolved around the fact that 
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veterinary staff are at a particularly high risk regarding zoonotic infections.  While other 
occupations that involve handling animals are at a lower risk than veterinary staff, it is 
important to note that they are still at risk.  Thus, Dr. Scheftel and Dr. Brigid Elchos got 
behind the idea of a Compendium of Veterinary Standard Precautions for Zoonotic 
Disease Prevention in Veterinary Personnel in order to minimize transmission of 
zoonotic pathogens from animals to veterinary personnel in private practice.  Because the 
issue of zoonotic disease and interspecies transmission is so broad, Dr. Scheftel and Dr. 
Elchos narrowed their focus to the explicit needs of veterinary personnel within private 
practices.  Thus, this Compendium is difficult to adapt to areas outside of veterinary 
practices because it was specifically written for a particular population and within a 
narrow scope.       
   
2. When and how did practitioners decide there was a need for a document covering this 
material? 
 
It was not practitioners, but veterinary and public health officials that identified the need 
for the Compendium.  After the 2003 MPXV infections in veterinarians and veterinary 
technicians, the National Association of State Public Health Veterinarians (NASPHV) 
Veterinary Infection Control Committee (VICC) identified zoonotic diseases of 
importance in the United States and worked together to develop a document that raises 
awareness of the scope of zoonotic disease risk, establishes practical, science-based 
veterinary infection control guidance, outlines specific veterinary issues and provides a 
model infection control plan that can be tailored to individual practice needs.  The 
NASPHV VICC wanted to highlight that veterinary personnel face occupational hazards 
as a result of zoonotic diseases on a daily basis.  The overall need for the Compendium 
was based on the fact that veterinary professionals are exposed to exotic and zoonotic 
infections, are exposed to bites and other trauma, and are exposed to potential needle 
stick injuries.  Thus, it is necessary to offer guidance for infection control to minimize the 
risk of infection and injury.   
 
3. Who is the champion (s) for the Compendium?   
 
Brigid L. Elchos, RN, DVM, (Co-Chair), State Public Health Veterinarian, Mississippi 
Board of Animal Health, Jackson, MS 39207 
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Joni M. Scheftel, DVM, MPH, DACVPM, (Co-Chair), State Public Health Veterinarian, 
Minnesota Department of Health, Saint Paul, MN 55155 
 
Both Dr. Elchos and Dr. Scheftel are the champions for the Compendium.  They were the 
two strongest voices pushing for its development, but they vigorously acknowledge that 
its creation and completeness is a result of a team effort by the NASPHV VICC.  
Documents of this nature that outline guidelines and provide models for infection control 
are best (and most often) put together by a committee, not an individual person.  
Committees consist of people with all different areas of expertise and thus provide a wide 
range of proficiencies.  To make an impact via a best practice or guidelines document, 
one must work with a talented and knowledgeable committee that can facilitate 
development and speak to all sub-issues that are pertinent to the overall topic of concern.  
 
4. Who has the authority to modify the Compendium and how can changes be made to the 
Compendium?  How is the Compendium information updated?   
 
The NASPHV VICC and Consultants to the Committee have the authority to modify the 
Compendium and are able to make changes to the document.  Every two years, the 
committee reconvenes and makes any necessary modifications.  These modifications are 
based mainly on evidence-based research outcomes, but clinic experiences are also 
considered.  The committee strives to obtain the most current evidence-based research on 
the topic and uses it to guide their Compendium modifications.  The changes must be 
agreed upon by the entire committee in order to be included in the updated Compendium.  
The committee came together in December of 2009 to make changes and develop the 
2010 Compendium.  The 2010 Compendium will most likely be published in the Journal 
of the American Veterinary Medical Association in August of 2010.    
 
5. Is there potential that the Compendium will be championed by the American Veterinary 
Medical Association (AVMA) and identified as a best practice guide by the AVMA? 
 
The AVMA currently does not endorse the Compendium as a best practice guide, but 
they do publish it in the Journal of the American Veterinary Medical Association 
(JAVMA).  The fact that the AVMA does continually publish the Compendium indicates 
that there is potential that the AVMA will move in that direction.  According to Dr. 
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Scheftel, the NASPHV VICC has discussed that the next step for the Compendium 
process is to get it endorsed by the AVMA and also by the American Animal Hospital 
Association (AAHA).  With an AAHA member on the NASPHV VICC, Dr. Scheftel has 
hopes that the AAHA endorsement will happen within the near future.       
 
6. Do you think the Compendium should be something that is used in all veterinary 
practices/hospitals?   
 
Absolutely! But, it should be modified to fit each individual practice.  Depending on the 
size of the practice, the procedures performed, and the animals seen in the practice or 
hospital, some sections of this Compendium are more useful than others.  Professionals in 
each practice need to decide what is most applicable to them and follow those particular 
guidelines accordingly.  Likewise, all veterinary practices should have a written infection 
control plan that is tailored to individual practice needs.  Because the Compendium 
committee strongly feels that all veterinary practices should have a written infection 
control plan, they developed a model infection control plan that can be accessed and 
modified by veterinary professionals outside of the NASPHV VICC.      
 
7. Should the use of the Compendium (and any modifications) be regulated state by state or 
through federal government? 
 
No!  Since the Compendium is not endorsed by the AVMA, it should not be regulated by 
government on any level.  It should be used as it is written – as a document that provides 
guidance for infection control that aims to minimize the risk of interspecies transmission 
of disease, aims to minimize the risk of occupational zoonotic infections and aims to 
minimize the risk of infection from new, emerging infectious diseases.  Also, 
governmental regulatory action on this issue would make “veterinary professionals too 
liable.”  Government involvement, regulatory action and governmental enforcement with 
this particular issue is not the way to go to gain industry buy-in, according to Dr. 
Scheftel.  The issue needs to be tackled within the industry by influential industry 
members for something such as the Compendium to become best practice.     
 
8. How is the Compendium currently being used in veterinary private practices?   
 
Unknown 
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9. How is the Compendium implemented by veterinary professionals in private practice?   
 
Unknown 
 
10. How often are the Compendium guidelines (and the Infection Control Plan Model) used 
in private practice?   
 
Unknown 
 
11. Do have any examples of when the Compendium (or parts of the Compendium) was used 
and can you describe the outcomes? 
 
Unknown 
 
12. What sections of the Compendium do you think relate most to public health and have 
potential for adaptation outside of veterinary hospitals?  Specifically, how can I use the 
Compendium to guide my own research? 
 
As stated before, Dr. Scheftel and Dr. Brigid Elchos got behind the idea of a 
Compendium of Veterinary Standard Precautions for Zoonotic Disease Prevention in 
Veterinary Personnel in order to minimize transmission of zoonotic pathogens from 
animals to veterinary personnel in private practice.  Thus, this Compendium is 
difficult to adapt to areas outside of veterinary private practices because it was 
specifically written for a particular population and within a narrow scope.  Also, Dr. 
Scheftel reiterated that documents of this nature that outline guidelines and provide 
models for infection control are best (and most often) put together by a committee, not an 
individual person.  To make an impact via a best practice or guidelines document for the 
horse show jumping industry, I must work with a talented and knowledgeable committee 
that can facilitate development and speak to all sub-issues that are pertinent to the overall 
topic of concern.  Moreover, members of that committee need to include doctors and 
researchers who are experts on MRSA in horses and who are prominent figures in the 
horse show industry in order to influence industry buy-in.  With that being said, Dr. 
Scheftel advises that the best approach to creating a document for my project at this point 
is not to necessarily adapt or modify the Compendium, but to emphasize what standard 
infection control precautions are and why they are important to use in the horse show 
industry as part of my results section (based off of research) and to create an infection 
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control plan that can be tailored to each horse show.  Dr. Scheftel believes I can modify 
the model infection control that is provided in the Appendix of the Compendium.       
         
13. What are your recommendations for future infection control documents?  What should 
these documents include?  
 
Future infection control documents need to be the result of a collaborative committee 
effort in order to make an impact and to provide and outline the best possible practices 
and guidelines.  This committee approach will also help to ensure industry buy-in and 
help recommendations gain credibility.  While future infection control documents will 
overlap with current documents, it is important to always be looking for new evidence-
based research that is emerging.  Future infection control documents should reflect the 
most current evidence-based research practices.  It should be noted that the evidence-
based research should be added to infection control documents in a user-friendly manner.  
Infection control plans should be practical and science-based.     
 
14. Do you have anything else to add or any other suggestions for me to consider as I move 
forward with my project? 
 
It is not appropriate to adapt or modify the Compendium in its entirety for use by an 
industry outside private veterinary practices.  It is also beyond the scope of a Master’s 
project to develop a “Compendium of Horse Show Jumping Standard Precautions for 
MRSA Prevention in Equine Personnel,” especially if I do not have sufficient specialist 
support and committee involvement.  However, certain outlined project aims (standard 
precautions to reduce MRSA zoonotic transmission, model infection control plan for 
MRSA and a MRSA informational and awareness brochure specific to the equine 
industry) will work well for the project and are able to be modified, according to Dr. 
Scheftel.  Developing an informational MRSA brochure specific to the equine industry is 
also a solid way of creating a user-friendly document for members of the horse show 
industry, if time allows.  Plus, disseminating this brochure at horse shows can help 
facilitate industry buy-in early on in the research process.  If I choose to continue this 
research in a doctoral program or in veterinary school research, I will need to network 
and gain support and assistance from specialized colleagues.   
